<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Complement Med Ther</journal-id><journal-id journal-id-type="iso-abbrev">BMC Complement Med Ther</journal-id><journal-title-group><journal-title>BMC Complementary Medicine and Therapies</journal-title></journal-title-group><issn pub-type="epub">2662-7671</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7678202</article-id><article-id pub-id-type="publisher-id">3146</article-id><article-id pub-id-type="doi">10.1186/s12906-020-03146-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of immunomodulatory effects of <italic>Boswellia sacra</italic> essential oil on T-cells and dendritic cells</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9599-050X</contrib-id><name><surname>Aldahlawi</surname><given-names>Alia M.</given-names></name><address><email>aaldahlawi@kau.edu.sa</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Alzahrani</surname><given-names>Amani T.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Elshal</surname><given-names>Mohamed F.</given-names></name><address><email>Mohamed.elshal@gebri.usc.edu.eg</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.412125.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0619 1117</institution-id><institution>Department of Biological Sciences, </institution><institution>Faculty of Sciences, King Abdulaziz University, </institution></institution-wrap>Jeddah, Saudi Arabia </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412125.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0619 1117</institution-id><institution>Immunology Unit, King Fahad Medical Research Center, </institution><institution>King Abdulaziz University, </institution></institution-wrap>Jeddah, Saudi Arabia </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.449877.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 4652 351X</institution-id><institution>Molecular Biology Department, </institution><institution>Genetic Engineering and Biotechnology Institute, University of Sadat City, </institution></institution-wrap>Sadat City, Egypt </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>20</volume><elocation-id>352</elocation-id><history><date date-type="received"><day>10</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>2</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1"><italic>Boswellia sacra</italic> resin has been commonly used as analgesic, antimicrobial, and anti-inflammatory properties, which reflect its immunomodulatory activity. Dendritic cells (DCs) are specialized antigen-presenting cells (APCs) and sentinel cells that regulate the immune response. This study aims at investigating whether crude essential oil extracted from <italic>Boswellia sacra</italic> resin (BSEO), has a potential effect on the phenotype and functions of human monocyte-derived DCs.</p></sec><sec><title>Methods</title><p id="Par2">Oil extract from the resin of <italic>Boswellia sacra</italic> was prepared by hydrodistillation using a custom made hydrodistiller. BSEO-mediated cell viability has been initially studied on human skin dermis cells (HSD) and DC precursors using quantitative and qualitative assays before applying on DCs. Human DCs were generated from differentiated peripheral blood monocytes cultured in media containing both GM-CSF and IL-4. DCs were exposed to 5&#x02009;&#x003bc;g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL of BSEO in vitro. Morphological, phonotypical, and functional properties studied with microscopy, flow cytometry, and ELISA.</p></sec><sec><title>Results</title><p id="Par3">Crude BSEO was found to interfere with the maturation and differentiation of DCs from precursor cells in the presence or absence of lipopolysaccharide (LPS). BSEO-treated DCs, cultured in the presence of LPS, reduced the ability of allogeneic T cells to proliferate compared to that co-cultured with LPS-stimulated DCs only. In addition, the endocytic capacity and secretion of IL-10 by DCs treated with BSEO was enhanced in comparison to LPS treated cells. Analysis of the chemical composition of BESO using GC-MS (Clarus 500 GC/MS, PerkinElmer, Shelton, CT) revealed the presence of compounds with several biological activities including antibacterial, antioxidant, and anti-inflammatory properties.</p></sec><sec><title>Conclusion</title><p id="Par4">Results indicated that BSEO deviates the differentiation of monocytes into immature DCs. Furthermore, stimulation of immature DCs with BSEO was unable to generate full DC maturation. However, these findings may potentially be employed to generate DCs with tolerogenic properties that are able to induce tolerance in diseases with hypersensitivity, autoimmunity as well as transplantation.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Dendritic cells</kwd><kwd><italic>Boswellia sacra</italic></kwd><kwd>Essential oil</kwd><kwd>Differentiation</kwd><kwd>Maturation</kwd><kwd>And tolerance</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004919</institution-id><institution>King Abdulaziz City for Science and Technology</institution></institution-wrap></funding-source><award-id>PS-35-190</award-id><principal-award-recipient><name><surname>Alzahrani</surname><given-names>Amani T.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par12">Burseraceae is one of the most popular aromatic plants used in incense, perfume, and as a preservative. The genus Boswellia belongs to the Burseraceae botanical family, well-known by the oilresin exuded from incisions in the trunk of the tree. It has a prolonged history of use in traditional medicines to mitigate or cure inflammatory diseases such as rheumatoid arthritis [<xref ref-type="bibr" rid="CR1">1</xref>]. Moreover, <italic>Boswellia sp</italic>. includes <italic>Boswellia sacra, Boswellia carteri,</italic> and <italic>Boswellia serrata</italic>, which demonstrate substantial applications in research. The pharmacological properties of <italic>Boswellia sp</italic>. have also been widely investigated both in vitro and in vivo (animals or humans) [<xref ref-type="bibr" rid="CR2">2</xref>]. The resin&#x02019;s anti-inflammatory activity may be attributed to its potential to regulate multiple inflammatory mediators including cytokines, and target various signal transductions [<xref ref-type="bibr" rid="CR3">3</xref>]. Furthermore, <italic>Boswellia sp</italic>. essential oil is a volatile constituent, which is mostly used in aromatherapy. Research has tried to identify and elucidate the pharmacological properties of <italic>Boswellia sp</italic>. essential oil [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par13">Dendritic cells (DCs) are one of the three mononuclear phagocyte system known for their exclusive characteristics [<xref ref-type="bibr" rid="CR5">5</xref>]. DCs contain distinct subpopulations critically essential for the generation of multiple functions in the immune system, which determine the outcome of immune responses. Immature DCs (imDCs) are located in the peripheral tissues where they work as sentinels and facilitate immune tolerance [<xref ref-type="bibr" rid="CR6">6</xref>]. After DCs are activated, they become mature DCs (mDCs), which critically required for priming na&#x000ef;ve T lymphocytes. Upon activation, na&#x000ef;ve T cells start to proliferate and differentiate into effector cells, which are needed for the promotion of the adaptive immune response against pathogens. On the other hand, the production of immune tolerance is crucial for the maintenance of self-tolerance under steady state conditions [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par14">Modulation of DCs with plant-derived natural products was documented in several scientific articles. Generally, the plant and their constituents may enhance the differentiation of DCs from precursors [<xref ref-type="bibr" rid="CR9">9</xref>], or modulate DC functions to either induce or suppress immune responses [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. To achieve such modulation, DC undergoes several phenotypical and functional changes. For instance, changes lead to up or downregulation of DC maturation markers including CD80, CD86, CD83, CD40, and HLA-DR, phagocytic activity, cytokine production, and the ability to activate CD4<sup>+</sup> T cells. For Example, <italic>Vigna angularis</italic> (an extract from Azuki bean), pinecone extract, and <italic>Mucuna pruviens</italic> var. exhibited differentiation and maturation of DCs in vitro [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Studies demonstrated that changes in the functional status of DCs may bind to pattern recognition receptors, therefore could be useful targets for infectious disease therapy. Accordingly, it has been reported that both soybean and peanut agglutinin were agonists for TLR4 in humans [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par15">Bearing in mind the powerful role of DCs functions in the immune system, we investigated the efficacy of using crude <italic>Boswellia sacra</italic> essential oil (BSEO) in the induction of DCs modulation. Therefore, the aim of the present study is to explore the impact of BSEO on human monocyte-derived dendritic cell differentiation, maturation, and functional activities.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Media and reagents</title><p id="Par16">Cells were grown in RPMI-1640 or DMEM complete growth media containing Heat-inactivated fetal bovine serum (FBS) (Gibco, USA), and Penicillin-streptomycin solution (Pen/Strep) (HyClone, South Logan, USA). Both Phosphate-buffered saline (PBS) and Hanks&#x02019; balanced salt solution (HBSS) were obtained from UFC Biotech (KSA). Lymphoprep&#x02122; - 1.077&#x02009;g/mL was purchased from Axis-Shield PoC AS (Norway). Purified <italic>Escherichia coli</italic> LPS and Dimethyl Sulfoxide (DMSO)-1.10&#x02009;g/mL (Sigma-Aldrich&#x000ae;, St. Louis, USA) was used. Vitamin D3 was purchased from Nature Made (USA). All CCR7, CD83, CD80, CD14, CD71 recombinant monoclonal antibodies, recombinant human interleukin 4 (IL-4), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were obtained from BioLegend&#x000ae; (San Diego, California). CD3 was purchased from Invitrogen (Carlsbad, California). Isotype control, CD11c, and CD86 recombinant monoclonal antibodies were purchased from R&#x00026;D systems (Minneapolis, MN, USA). Lithium Heparin tubes were from Xinle sci&#x00026;tech co., ltd. (China). Magnesium Sulphate anhydrous (anh. MgSO4) (M.W. =120, 37) was purchased from Panreac Quimica SA, Barcelona, Spain. Camptothecin (CPT) (Sigma Aldrich&#x000ae;, St. Louis, USA) was used.</p></sec><sec id="Sec4"><title>Preparation of <italic>Boswellia sacra</italic> essential oil (BSEO)</title><p id="Par17"><italic>Boswellia sacra</italic> oleogum resin was purchased from Muttrah Souq in Muscat city, the capital of the Sultanate of Oman. Crude BSEO was extracted via hydrodistillation done using a regular hydrodistiller. The oleogum resins (100&#x02009;g) were mixed with 500&#x02009;mL distilled water and heated at 55&#x02009;&#x000b0;C until thick solution was formed [<xref ref-type="bibr" rid="CR15">15</xref>]. Then, the temperature of the hydrodistiller was increased up to 78&#x02009;&#x000b0;C and remained for 3&#x02009;h. The resulting mixture was filtered using a 0.22&#x02009;&#x003bc;m filter (CHMLAB Group 08205, Barcelona (SPAIN), EEC). Finally, the crude essential oil layer was separated manually using a sterilized plastic dropper. The collected essential oil was dried over anhydrous MgSO4. The harvested essential oil was stored in sealed vials at &#x02212;&#x02009;80&#x02009;&#x000b0;C until use. The stock solution of BSEO was prepared by dissolving in DMSO (1:1) to obtain an initial concentration of 25&#x02009;mg/mL. Then, the stock solution was diluted in culture media to get the concentrations at 5&#x02009;&#x003bc;g/mL, 10&#x02009;<italic>&#x003bc;</italic>g/mL, 15&#x02009;<italic>&#x003bc;</italic>g/mL, 20&#x02009;<italic>&#x003bc;</italic>g/mL, and 50&#x02009;<italic>&#x003bc;</italic>g/mL.</p></sec><sec id="Sec5"><title>Cell line culture</title><p id="Par18">Normal human skin dermis cell line (HSD) was obtained from Alzamil chair for cancer research and ethically approved by King Fahad Medical Center, Jeddah, KSA. HSD cell line was cultured in complete DMEM growth medium at a density of 1&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/well and 1.5&#x02009;mL/well in 12-well plates. Cells were grown in a 5% CO<sub>2</sub> incubator at 37&#x02009;&#x000b0;C in a humidified atmosphere. It was passaged twice weekly or when cells were about 70&#x02013;80% confluence [<xref ref-type="bibr" rid="CR16">16</xref>].</p></sec><sec id="Sec6"><title>DCs differentiation and maturation</title><p id="Par19">The present study was approved by the research ethics committee and performed at the Immunology Unit at KFMRC, KAU. DCs isolation and differentiation were performed as reported by others [<xref ref-type="bibr" rid="CR17">17</xref>]. Briefly, Heparinized human peripheral blood was diluted in HBSS, and Peripheral blood mononuclear cells (PBMCs) were separated by Lymphoprep density gradient centrifugation. Cells were washed and resuspended in red blood cell lysis buffer then washed twice with HBSS. A total of 50&#x02009;&#x000d7;&#x02009;10<sup>6</sup> PBMCs were resuspended in RPMI-1640 medium and plated in a 12 well plate at a density of 5&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/mL and allowed to adhere for 2&#x02009;h at 37&#x02009;&#x000b0;C in a 5% CO<sub>2</sub> incubator. Non-adherent cells were gently removed by washing several times with warm RPMI-1640 medium and the remaining adherent cells (monocytes) were used or cultured for further investigations. For DCs differentiation, adherent cells were cultivated in complete RPMI-1640 media containing IL-4 (50&#x02009;ng/mL) and GM-CSF (100&#x02009;ng/mL) for 7 days. Cultured cells were further fed on day three with complete RPMI-1640 media supplemented with the same concentration of cytokines.</p></sec><sec id="Sec7"><title>Cell viability assay</title><p id="Par20">HSD cells (at density of 1&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/well and 1.5&#x02009;mL/well in 12-well plates) and adherent monocytes were treated with crude BSEO at concentrations of 5&#x02009;&#x003bc;g/mL, 10&#x02009;<italic>&#x003bc;</italic>g/mL, 15&#x02009;<italic>&#x003bc;</italic>g/mL, 20&#x02009;<italic>&#x003bc;</italic>g/mL, and 50&#x02009;<italic>&#x003bc;</italic>g/mL. DMSO (&#x0003c;&#x02009;0.2% that had no toxic effect on cells) was used as control. After 24&#x02009;h, cells were collected, washed, and resuspended in PBS. Cytotoxicity was determined by the trypan blue exclusion test by mixing an equal volume of 0.4% trypan blue dye with the cell suspension [<xref ref-type="bibr" rid="CR18">18</xref>]. Cellular viability was determined using an inverted microscope (Nikon eclipse Ti, Tokyo, Japan) supplemented with digital camera software (NIS-Elements F 3.2, Nikon, Tokyo, Japan.</p></sec><sec id="Sec8"><title>DCs differentiation and maturation assays</title><p id="Par21">To investigate the capability of BSEO to induce differentiation of monocytes into imDCs, 5&#x02009;&#x003bc;g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL BSEO were added separately to adherent monocytes in the absence of cytokines. In parallel, adherent monocytes were also cultured in the presence of cytokines for comparison purposes. For the determination of DC maturation, cells were stimulated for further 24&#x02009;h with either BSEO at 5&#x02009;&#x003bc;g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL. Vitamin D3 at 12.5&#x02009;ng/mL was used to induce tolerogenic DCs. Mature DCs were achieved by adding LPS (1&#x02009;&#x003bc;g/mL) as a positive control and imDCs were left unstimulated or stimulated with 1% of DMSO. The effects of BSEO were also investigated on 1&#x02009;<italic>&#x003bc;</italic>g/mL LPS stimulated DCs [<xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec9"><title>Flow cytometry</title><p id="Par22">All BSEO treated and untreated cells were analyzed by Navios flow cytometer (Beckman Coulter Life Science, USA) following induction of differentiation or maturation. Cells were harvested, washed, and counted before staining. Then cells were stained with recombinant monoclonal antibodies including APC-conjugated anti-CD14, FITC-conjugated anti-CD11c, anti-HLA-DR, anti-CD83, anti-CD80, anti-CD86, and anti-CCR7 for 30&#x02009;min at 4&#x02009;&#x000b0;C. For negative control staining, appropriate conjugated isotypes were used. Following staining, all cells were washed with cold PBS and resuspended in 500&#x02009;&#x003bc;L of PBS. Data were acquired and analyzed by Navios software (Beckman coulter life science, USA) [<xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec10"><title>Apoptosis assay</title><p id="Par23">To determine the effects of BSEO treatment on the induction of apoptosis or necrosis in DCs, apoptosis detection kit (TACS&#x000ae;Annexin V-FITC, Trevigen, Gaithersburg, USA) was used and performed according to the manufacturer&#x02019;s guidelines. CPT was used as an apoptosis inducer at a concentration of 10&#x02009;mM for 4&#x02009;h and purchased from Sigma Aldrich&#x000ae;,St. Louis, USA. Briefly, cells were collected, washed once, and resuspended in 100&#x02009;&#x003bc;L of Annexin-V reagent. Cells were left in the dark for 15&#x02009;min at room temperature. Finally, 400&#x02009;&#x003bc;L of 1X binding buffer was added to stained cells and acquired by Navios flow cytometry (Beckman coulter life science, USA) within 1&#x02009;h and analyzed using Navios software [<xref ref-type="bibr" rid="CR20">20</xref>]. Ten <italic>&#x003bc;</italic>L of PI was added to the cells prior to analysis by flow cytometry. Consequently, viable cells do not take any color (Annexin V&#x02212;/PI-), early apoptotic cells are green (Annexin V+/PI-), late apoptotic cells are green and orange (Annexin V+/PI+), and necrotic cells are orange (Annexin V&#x02212;/PI+).</p></sec><sec id="Sec11"><title>Mixed lymphocytes reaction (MLR) assay</title><p id="Par24">For the induction of allogenic MLR, stimulated DCs (as a stimulator) were harvested, washed, and co-cultured with fresh allogeneic PBMCs (as a responder) in a ratio 1:10 for 3 days at 37&#x02009;&#x000b0;C in a 5% CO<sub>2</sub> incubator. Allogeneic PBMCs were used as a source of T cells. For comparison, imDCs and PBMCs were cultured separately and used as control. After 3 days, cells were washed, counted, and stained with anti-CD3 plus anti-CD71 for 30&#x02009;min at 4&#x02009;&#x000b0;C. Later, cells were washed twice and re-suspended in 200&#x02009;&#x003bc;L PBS supplemented with 2% FBS. Finally, stained cells were acquired and analyzed by Navios flow cytometry and software (Beckman coulter life science, USA) [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec12"><title>Endocytosis assay</title><p id="Par25">To determine the internalization capability of stimulated and unstimulated DCs, cells were collected and counted prior to staining. Harvested cells were washed and incubated with prewarm RPMI-1640 media without serum containing 1&#x02009;mg/mL FITC-dextran (MW 40000&#x02009;Da powder, UFC Biotech, KSA) at either 4&#x02009;&#x000b0;C (negative control) or 37&#x02009;&#x000b0;C (positive control) for 3&#x02009;h. Then, cells were washed with 5% ice-cold PBS supplemented FBS three times. Endocytosis was assessed by flow cytometry and was presented as the percentage of the cells that endocytosed FITC-dextran [<xref ref-type="bibr" rid="CR22">22</xref>]. Data analysis was performed using Navios flow cytometer (Beckman coulter life science, USA).</p></sec><sec id="Sec13"><title>Cytokine determination</title><p id="Par26">The concentrations of IL-12p70 and IL-10 cytokines released by stimulated DCs were quantified by sandwich ELISA using reagents from ELISA MAX&#x02122; Deluxe Sets (BioLegend&#x000ae;, San Diego, California, USA) as described by manufacturer instructions. Cell culture supernatants of stimulated DCs, without or with BSEO, were collected and then filter sterilized and stored at &#x02212;&#x02009;20&#x02009;&#x000b0;C. The absorbance value was estimated using a microplate reader at 450&#x02009;nm within 30&#x02009;min. The minimal detection level for this assay was 2&#x02009;pg/mL for IL-10 and 4&#x02009;pg/mL for IL-12. The absorbance value was estimated using a microplate reader (BioTek, Vermont, USA) at 450&#x02009;nm within 30&#x02009;min. The data were analyzed with computer-based standard curve [<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec><sec id="Sec14"><title>Microscopy</title><p id="Par27">Throughout the culturing, cells were visualized and photographed using an inverted phase-contrast microscope (Nikon eclipse T&#x000a1;-S, Tokyo, Japan) equipped with digital camera software (Nikon&#x02019;s Digital Sight DS-U3, Tokyo, Japan).</p></sec><sec id="Sec15"><title>Gas chromatography mass spectrometry (GC/MS) analyses</title><p id="Par28">BESO was analyzed using a gas chromatograph-mass spectrometer (GC/MS); Clarus 500 GC/MS (PerkinElmer, Shelton, CT] as previously described [<xref ref-type="bibr" rid="CR24">24</xref>]. The software controller/integrator was TurboMass, 5.4.2.1617 (PerkinElmer) and Teknokroma TR-CN100 GC capillary column, (60&#x02009;m&#x02009;&#x000d7;&#x02009;0.25&#x02009;mm ID&#x000d7;&#x02009;0.20&#x02009;&#x003bc;m df) was used (Teknokroma, Analitica SA, Barcelona, Spain). The column temperature program was: 80&#x02009;&#x000b0;C hold for 5&#x02009;min, increased to 150&#x02009;&#x000b0;C (rate, 5&#x02009;&#x000b0;C/min), and held for 5&#x02009;min, increased to 270&#x02009;&#x000b0;C (rate, 20&#x02009;&#x000b0;C/min) and hold for 5&#x02009;min. The injector temperature was 220&#x02009;&#x000b0;C. MS scan was from 45 to 350&#x02009;m/z. The total ion chromatogram was recorded from 45 to 350&#x02009;m/z. The targeted peaks were extracted by the knowledge of major m/z fragments, averaged masses at the peak top, and searched for matched compounds using mass spectrometry data bank NIST2008 database. The percentage composition of the essential oil was computed by the normalization method from the GC peak area measurements [<xref ref-type="bibr" rid="CR24">24</xref>].</p></sec><sec id="Sec16"><title>Statistical analysis</title><p id="Par29">Data from at least three independent experiments from three different independent individuals were presented as mean&#x02009;&#x000b1;&#x02009;standard deviation. Student&#x02019;s <italic>t</italic>-test (Excel 2016) was used to calculate the statistically significant differences between the results. The significant difference was considered when *<italic>P</italic>-value &#x0003c;&#x02009;0.05, **<italic>P</italic>-value &#x0003c;&#x02009;0.01, and ***<italic>P</italic>-value &#x0003c;&#x02009;0.001.</p></sec></sec><sec id="Sec17"><title>Results</title><sec id="Sec18"><title>Effect of BSEO on cellular viability</title><p id="Par30">The cytotoxic effect of crude BSEO was determined against the HSD cell line and peripheral blood monocytes. Stimulation of cells with different concentrations of crude BSEO for 24&#x02009;h showed decreased in cell viability compared to control untreated cells. The percentage of cell viability was decreased along with increased oil concentration from 5 to 50&#x02009;&#x003bc;g/mL. HSD cells treated with 50-&#x003bc;g/mL crude BSEO showed a highly significant decrease in viability 52.1&#x02009;&#x000b1;&#x02009;2.9 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01). Similarly, 50&#x02009;&#x003bc;g/mL crude BSEO induced significant decrease in monocytes viability 72.5&#x02009;&#x000b1;&#x02009;7.3 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). Therefore, 5&#x02009;<italic>&#x003bc;</italic>g/mL and 10&#x02009;<italic>&#x003bc;</italic>g/mL concentrations of crude BSEO were selected for this study (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Viabilities of HSD cells and peripheral blood monocytes. Trypan blue exclusion assay was used to determine the viabilities of cells upon treatment with different concentrations of crude BSEO as determined by</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Cells (%)</th><th colspan="6">BSEO Concentrations (&#x003bc;g/mL)</th></tr><tr><th>Control</th><th>5</th><th>10</th><th>15</th><th>20</th><th>50</th></tr></thead><tbody><tr><td><bold>HSD</bold></td><td char="&#x000b1;" align="char">96.1&#x000a0;&#x000b1;&#x000a0;1.6</td><td>95.1&#x000a0;&#x000b1;&#x000a0;3.2</td><td>92.6&#x000a0;&#x000b1;&#x000a0;5.8</td><td>88.5&#x000a0;&#x000b1;&#x000a0;0.5</td><td>87.6&#x000a0;&#x000b1;&#x000a0;5.7</td><td>52.1&#x000a0;&#x000b1;&#x000a0;2.9**</td></tr><tr><td><bold>PBM</bold></td><td char="&#x000b1;" align="char">96.1&#x000a0;&#x000b1;&#x000a0;0.4</td><td>90.9&#x000a0;&#x000b1;&#x000a0;0.2</td><td>89.3&#x000a0;&#x000b1;&#x000a0;1.2</td><td>87.6&#x000a0;&#x000b1;&#x000a0;4.9</td><td>84.9&#x000a0;&#x000b1;&#x000a0;7.7</td><td>72.5&#x000a0;&#x000b1;&#x000a0;7.3*</td></tr></tbody></table><table-wrap-foot><p>Data demonstrated as percentages of viability&#x02009;&#x000b1;&#x02009;SD and presented as mean of three independent experiments</p><p>(*) Referred to significant value compared to control untreated viable cells, where *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec19"><title>Effect of BSEO on monocytes differentiation into DCs</title><p id="Par31">Monocytes were cultured with crude BSEO at 5&#x02009;<italic>&#x003bc;</italic>g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL to test the ability of crude BSEO to encourage differentiation of monocytes into DCs. In parallel, monocytes were cultured either with GM-CSF plus IL-4 or 0.1% DMSO. After the incubation period, cells were investigated for DC cell surface markers. The results showed that crude BSEO did not affect cell phenotype compared to positive controls cultured with GM-CSF plus IL-4. The presence of BSEO in monocytes&#x02019; culture interfered with their differentiation into DCs. Whereas, cytokine-treated cells expressed low levels of CD14 (2.7&#x02009;&#x000b1;&#x02009;1.5) and high levels of CD11c (97.2&#x02009;&#x000b1;&#x02009;2.1) as typical immature DCs; in contrast, cells incubated with BSEO were significantly expressed high levels of CD14 (87.05&#x02009;&#x000b1;&#x02009;2.6) and low levels of CD11c (5.45&#x02009;&#x000b1;&#x02009;3.6). The expression of HLA-DR was slightly decreased in BSEO-treated cells compared to cytokine-treated cells, although no significant differences were observed. Moreover, cytokine-treated cells showed significant differences in the expression of CD86 in comparison to BSEO-treated cells and negative control cells as shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. The expression of CD86 was also positive on the PMBCs before culturing (data not shown).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Flow cytometry analysis of peripheral blood monocytes. Cell surface markers Expression upon differentiation in response to BSEO</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Cell surface markers<break/>(%)</th><th rowspan="2">Negative control 0.1%DMSO</th><th colspan="3">Differentiation inducers</th></tr><tr><th>Positive control (GM-CSF plus IL-4)</th><th>BSEO 5&#x02009;&#x003bc;g/mL</th><th>BSEO 10&#x02009;<bold><italic>&#x003bc;</italic></bold>g/mL</th></tr></thead><tbody><tr><td>CD14</td><td>87.1&#x000a0;&#x000b1;&#x000a0;0.8</td><td>2.7&#x000a0;&#x000b1;&#x000a0;1.5</td><td>87.05&#x000a0;&#x000b1;&#x000a0;2.6***</td><td>88.6&#x000a0;&#x000b1;&#x000a0;1***</td></tr><tr><td>CD11c</td><td>8.9&#x000a0;&#x000b1;&#x000a0;4.7</td><td>97.2&#x000a0;&#x000b1;&#x000a0;2.1</td><td>5.45&#x000a0;&#x000b1;&#x000a0;3.6***</td><td>8.7&#x000a0;&#x000b1;&#x000a0;2.2***</td></tr><tr><td>HLA-DR</td><td>96.9&#x000a0;&#x000b1;&#x000a0;0.5</td><td>99.4&#x000a0;&#x000b1;&#x000a0;0.8</td><td>90.9&#x000a0;&#x000b1;&#x000a0;8.9</td><td>95.5&#x000a0;&#x000b1;&#x000a0;1.3</td></tr><tr><td>CD86</td><td>57.3&#x000a0;&#x000b1;&#x000a0;2.9</td><td>8.9&#x000a0;&#x000b1;&#x000a0;2.5</td><td>77.8&#x000a0;&#x000b1;&#x000a0;6.9**</td><td>57.9&#x000a0;&#x000b1;&#x000a0;13.4*</td></tr></tbody></table><table-wrap-foot><p>Data presented as mean percentages (%) of markers expression obtained from three different individuals&#x02009;&#x000b1;&#x02009;SD</p><p>(*) Referred to significant value compared to the positive control, where * <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, *** <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec20"><title>Effect of BSEO on DC maturation</title><p id="Par32">To study the effects of BSEO treatment on DC maturation, cells were isolated and cultured as described previously in the materials and methods. Throughout the culturing period, cells were visualized and photographed using an inverted phase-contrast microscope. On day eight after 24&#x02009;h of stimulation, typical distinctive differences of imDCs and mDCs were observed. Typical morphology of differentiated imDCs appeared with irregular shape with short cytoplasmic projections (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a). Unlike, LPS stimulated DCs which appeared elongated and more irregular in shape with numerous and long cytoplasmic projections (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). However, BSEO-treated cells showed as typical as imDCs (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c &#x00026; d).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Morphology of DCs treated with crude BSEO. DCs were treated with either crude BSEO or LPS for 24&#x02009;h and visualized using an inverted microscope. <bold>a</bold> Represents 0.1%DMSO-treated DCs that show a typical morphology of imDCs, which appeared irregular shape with short cytoplasmic projections. <bold>b</bold> Represents LPS-treated DCs that show a typical morphology of mDCs which seen elongated with long cytoplasmic projection. <bold>c</bold> Represents DCs treated with 5&#x02009;<italic>&#x003bc;</italic>g/mL of BSEO and <bold>d</bold> DCs treated with 10&#x02009;<italic>&#x003bc;</italic>g/mL of BSEO that exhibited imDCs features. Arrows pointed to DC projections. Photographed by phase-contrast inverted microscope (Original magnifications were 400X) at Immunology unit, KFMRC, King Abdulaziz University</p></caption><graphic xlink:href="12906_2020_3146_Fig1_HTML" id="MO1"/></fig></p><p id="Par33">To evaluate the effects of crude BSEO treatments on the expression of cell surface markers of DC after 24&#x02009;h, the percentages of CD14, CD11c, HLA-DR, CD83, CD80, CD86, and CCR7 expression were analyzed by flow cytometry. Our results showed a decreased percentage of CD14 marker on crude BSEO treated DCs and decreased expression of HLA-DR and CD11c markers similar to control unstimulated DCs and vitamin D3-stimulated DCs (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Whereas the mean percentages of cells expressing maturation marker CD83, co-stimulatory molecules CD80 / CD86, and homing receptor CCR7 were remained significantly lower at both 5&#x02009;&#x003bc;g/mL and 10&#x02009;<italic>&#x003bc;</italic>g/mL doses of BSEO in comparison to DCs treated with LPS. These results indicated the immature status of BSEO treated DCs.
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Flow cytometry analysis of dendritic cells. DCs surface markers expression after stimulation with different inducers including BSEO</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Cell surface markers (%)</th><th rowspan="2">Negative control 0.1%DMSO</th><th colspan="4">Stimulation inducers</th></tr><tr><th>Positive control LPS</th><th>BSEO 5&#x02009;<bold><italic>&#x003bc;</italic></bold>g/mL</th><th>BSEO 10&#x02009;<bold><italic>&#x003bc;</italic></bold>g/mL</th><th>VIT- D3</th></tr></thead><tbody><tr><td>CD14</td><td>2.0&#x000a0;&#x000b1;&#x000a0;0.3</td><td>1.7&#x000a0;&#x000b1;&#x000a0;0.4</td><td>2.7&#x000a0;&#x000b1;&#x000a0;0.4</td><td>3.6&#x000a0;&#x000b1;&#x000a0;0.3</td><td>92.7&#x000a0;&#x000b1;&#x000a0;10.7</td></tr><tr><td>CD11c</td><td>94.7&#x000a0;&#x000b1;&#x000a0;1.8</td><td>95.7&#x000a0;&#x000b1;&#x000a0;0.2</td><td>95.0&#x000a0;&#x000b1;&#x000a0;2.7</td><td>96.1&#x000a0;&#x000b1;&#x000a0;0.7</td><td>94.8&#x000a0;&#x000b1;&#x000a0;0.5</td></tr><tr><td>HLA-DR</td><td>96.0&#x000a0;&#x000b1;&#x000a0;2.1</td><td>98.8&#x000a0;&#x000b1;&#x000a0;0.3</td><td>89.4&#x000a0;&#x000b1;&#x000a0;15.5</td><td>91.0&#x000a0;&#x000b1;&#x000a0;14.2</td><td>92.7&#x000a0;&#x000b1;&#x000a0;0.5</td></tr><tr><td>CD83</td><td>4.49&#x000a0;&#x000b1;&#x000a0;0.5</td><td>82.4&#x000a0;&#x000b1;&#x000a0;1.2</td><td>4.6&#x000a0;&#x000b1;&#x000a0;0.9***</td><td>4.5&#x000a0;&#x000b1;&#x000a0;2.3***</td><td>4.4&#x000a0;&#x000b1;&#x000a0;2***</td></tr><tr><td>CD80</td><td>49.1&#x000a0;&#x000b1;&#x000a0;7.3</td><td>97.0&#x000a0;&#x000b1;&#x000a0;3.3</td><td>54.5&#x000a0;&#x000b1;&#x000a0;7.5***</td><td>54.8&#x000a0;&#x000b1;&#x000a0;11.9**</td><td>55.2&#x000a0;&#x000b1;&#x000a0;10.4**</td></tr><tr><td>CD86</td><td>25.8&#x000a0;&#x000b1;&#x000a0;23.7</td><td>97.1&#x000a0;&#x000b1;&#x000a0;2.1</td><td>24.3&#x000a0;&#x000b1;&#x000a0;15.0***</td><td>57.9&#x000a0;&#x000b1;&#x000a0;13.4***</td><td>22.7&#x000a0;&#x000b1;&#x000a0;21.3</td></tr><tr><td>CCR7</td><td>38.5&#x000a0;&#x000b1;&#x000a0;19.9</td><td>73.1&#x000a0;&#x000b1;&#x000a0;1.9</td><td>73.4&#x000a0;&#x000b1;&#x000a0;19.4*</td><td>45.4&#x000a0;&#x000b1;&#x000a0;16.4*</td><td>46&#x000a0;&#x000b1;&#x000a0;16.2*</td></tr></tbody></table><table-wrap-foot><p>Data presented as mean percentages (%) of markers expression of dendritic cells obtained from three different individuals&#x02009;&#x000b1;&#x02009;SD. Note: (*) Referred to significant difference when compared to the positive control, where *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01, and ***<italic>P</italic> &#x0003c; 0.001</p></table-wrap-foot></table-wrap></p><p id="Par34">Data in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> showed that LPS stimulated DCs were expressed full maturation properties and turned into mDCs. However, stimulation with LPS in the presence of crude BSEO at 5&#x02009;&#x003bc;g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL did not show the same properties. The surface expression of CD86 and CD83 markers were assessed. Data indicated that the expression of CD86 was slightly reduced on DCs treated with the combined treatment in comparison to LPS-stimulated DCs. However, this reduction was not significant. Interestingly, data demonstrated that the exposure of DCs to the combined effect of LPS and BSEO (both 5&#x02009;<italic>&#x003bc;</italic>g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL), significantly suppressed the expression of the maturation marker CD83 (<italic>P</italic>-value &#x0003c;&#x02009;0.001), even in the existence of LPS compared to DCs treated with LPS alone.
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Flow cytometry analysis of the expression of CD83 and CD86 markers. LPS-stimulated DCs in combination with different inducers were evaluated for the expression of CD83 and CD86 markers</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Cell surface markers (%)</th><th rowspan="2">Negative control 0.1%DMSO</th><th colspan="3">Stimulation inducers</th></tr><tr><th>Positive control LPS</th><th>LPS + BSEO 5&#x02009;&#x003bc;g/mL</th><th>LPS + BSEO 10&#x02009;<bold><italic>&#x003bc;</italic></bold>g/mL</th></tr></thead><tbody><tr><td>CD86</td><td>7.6&#x000a0;&#x000b1;&#x000a0;2.9</td><td>96.5&#x000a0;&#x000b1;&#x000a0;2.2</td><td>82.0&#x000a0;&#x000b1;&#x000a0;11.8</td><td>88.7&#x000a0;&#x000b1;&#x000a0;4.0</td></tr><tr><td>CD83</td><td>5.5&#x000a0;&#x000b1;&#x000a0;1.9</td><td>82.4&#x000a0;&#x000b1;&#x000a0;1.2</td><td>27.8&#x000a0;&#x000b1;&#x000a0;2.2***</td><td>36.6&#x000a0;&#x000b1;&#x000a0;2.2***</td></tr></tbody></table><table-wrap-foot><p>Data presented as mean percentages of markers expression obtained from three different individuals&#x02009;&#x000b1;&#x02009;SD. Note: (*) Referred to significant difference when compared to LPS-stimulated DCs only, where ***<italic>P</italic> &#x0003c; 0.001</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec21"><title>Effect of BSEO on DC apoptosis</title><p id="Par35">To determine whether crude BSEO-induce DCs apoptosis, the expression of plasma membrane phosphatidylserine was detected using the Annexin V-FITC assay. To this end, treated DCs were compared to CPT-treated DCs as a positive control for apoptotic DCs. Data in Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref> revealed that no significant differences were found between DCs treated with any of the stimulants on the induction of early or late apoptosis compared to unstimulated controls. Whereas, CPT-treated DCs expressed significantly greater percentages of apoptosis (36%) compared to control unstimulated cells. In all treatment conditions, the viability of cells was not affected significantly.
<table-wrap id="Tab5"><label>Table 5</label><caption><p>Percentages of viable, early apoptotic, late apoptotic, and necrotic DCs upon stimulation. The results shown were from three independent experiments with mean&#x02009;&#x000b1;&#x02009;SD</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Type (%)</th><th colspan="6">Treatment</th></tr><tr><th>LPS</th><th>BSEO-5</th><th>BSEO-10</th><th>VIT-D3</th><th>CPT</th><th>Control</th></tr></thead><tbody><tr><td>Viable cells</td><td>88.6&#x02009;&#x000b1;&#x02009;1.0</td><td>88.2&#x02009;&#x000b1;&#x02009;4.8</td><td>87.4&#x02009;&#x000b1;&#x02009;3.9</td><td>87.5&#x02009;&#x000b1;&#x02009;7.3</td><td>61.3&#x000a0;&#x000b1;&#x000a0;5.8</td><td>88.7&#x02009;&#x000b1;&#x02009;5.4</td></tr><tr><td>Early Apoptosis</td><td>*** 3.1&#x02009;&#x000b1;&#x02009;0.8</td><td>*** 2.5&#x02009;&#x000b1;&#x02009;1.8</td><td>*** 3.9&#x02009;&#x000b1;&#x02009;0.9</td><td>*** 1.8&#x02009;&#x000b1;&#x02009;1.7</td><td>29.5&#x000a0;&#x000b1;&#x000a0;0.8</td><td>*** 4.7&#x02009;&#x000b1;&#x02009;2.4</td></tr><tr><td>Late Apoptosis</td><td>4.7&#x02009;&#x000b1;&#x02009;2.1</td><td>4.7&#x02009;&#x000b1;&#x02009;1.9</td><td>5.4&#x02009;&#x000b1;&#x02009;1.0</td><td>3&#x02009;&#x000b1;&#x02009;1.8</td><td>6.6&#x000a0;&#x000b1;&#x000a0;1.0</td><td>2.5&#x02009;&#x000b1;&#x02009;0.5</td></tr><tr><td>Necrosis</td><td>2.1&#x02009;&#x000b1;&#x02009;0.4</td><td>3.8&#x02009;&#x000b1;&#x02009;1.2</td><td>2.3&#x02009;&#x000b1;&#x02009;0.7</td><td>2.3&#x02009;&#x000b1;&#x02009;0.3</td><td>3.2&#x000a0;&#x000b1;&#x000a0;1.8</td><td>2.3&#x02009;&#x000b1;&#x02009;0.9</td></tr></tbody></table><table-wrap-foot><p>Note: (*) Referred to significant difference when compared to the positive control treated with CPT, where ***(<italic>P</italic> &#x0003c; 0.001)</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec22"><title>Effect of BSEO on allogeneic T cells proliferation</title><p id="Par36">The ability of BSEO-treated DCs to prompt proliferation of allogeneic T cells was examined by MLR assay. The co-culture of BSEO-treated DCs with allogenic T cells was analyzed by flow cytometry. T cell proliferation capability was calculated by the percentage of CD3<sup>+</sup>CD71<sup>+</sup>proliferative T cells. Data demonstrated that the ability of BSEO-treated DCs to induce proliferation of allogeneic T cells were similar to vitamin D3-treated DCs but significantly lower (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01 for 5&#x02009;&#x003bc;g/mL-treated DCs and 0.001 for 10&#x02009;&#x003bc;g/mL-treated DCs) than the capacity of LPS-treated DCs. Interestingly, BSEO reduces the capability of T cells to proliferate even in combination with LPS when compared to cells treated with LPS alone (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).
<fig id="Fig2"><label>Fig. 2</label><caption><p>Effects of crude BSEO on T cell proliferation. Data represented the mean percentages of CD3<sup>+</sup>CD71<sup>+</sup> T cells (&#x000b1; SD) co-cultured with stimulated DCs as determined using MLR assay. Results were performed from five independent experiments. Mean was significant when compared to LPS-stimulated DCs (*<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01)</p></caption><graphic xlink:href="12906_2020_3146_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec23"><title>Effect of BSEO on DC endocytic capacity</title><p id="Par37">To explore the impact of BSEO on the endocytic capacity of monocyte-derived DCs, the FITC-dextran uptake assay was performed. LPS-stimulated DCs showed a significant reduction in FITC-dextran uptake (18.5&#x02009;&#x000b1;&#x02009;9, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) compared to control unstimulated DCs. Whereas vitamin D3-treated DCs showed no significant difference in FITC-dextran uptake compared to controls. BSEO treatments (5&#x02009;&#x003bc;g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL) were also unable to reduce dextran uptake by DCs, as uptake percentages remained similar to imDCs (Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>).
<table-wrap id="Tab6"><label>Table 6</label><caption><p>Percentages of FITC-dextran uptake by stimulated DCs. Data are collected from three independent experiments</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Treatments</th><th>At 37 &#x000b0; C (Mean&#x02009;&#x000b1;&#x02009;SD)</th><th>At 4 &#x000b0; C (Mean&#x02009;&#x000b1;&#x02009;SD)</th></tr></thead><tbody><tr><td>Mature DCs (LPS)</td><td>18.5&#x000a0;&#x000b1;&#x000a0;9.0***</td><td>0.7&#x000a0;&#x000b1;&#x000a0;0.2</td></tr><tr><td>Immature DCs (No-LPS)</td><td>64.34&#x000a0;&#x000b1;&#x000a0;10.7</td><td>0.7&#x000a0;&#x000b1;&#x000a0;0.5</td></tr><tr><td>VIT-D3</td><td>68.73&#x000a0;&#x000b1;&#x000a0;7.4</td><td>0.7&#x000a0;&#x000b1;&#x000a0;0.7</td></tr><tr><td>BSEO-5</td><td>55.1&#x000a0;&#x000b1;&#x000a0;5.0</td><td>0.7&#x000a0;&#x000b1;&#x000a0;0.7</td></tr><tr><td>BSEO-10</td><td>60.8&#x000a0;&#x000b1;&#x000a0;11.0</td><td>0.4&#x000a0;&#x000b1;&#x000a0;0.4</td></tr></tbody></table><table-wrap-foot><p>Note: (*) Referred to significant value compared to the control immature DCs (0.1% DMSO-treated DCs), where ***<italic>P</italic> &#x0003c; 0.001</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec24"><title>Effect of BSEO on IL-10 and IL-12 secretion by DCs</title><p id="Par38">The immunomodulatory effect of crude BSEO on DCs was investigated by the determination of both IL-10 and IL-12p70 levels in DCs culture supernatant after 24&#x02009;h treatment using ELISA assay. As illustrated in Table&#x000a0;<xref rid="Tab7" ref-type="table">7</xref>, each of LPS, vitamin D3, and BSEO (5&#x02009;<italic>&#x003bc;</italic>g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL) stimulated the secretion of IL-10 and IL-12p70. However, BSEO-treated DCs secreted higher levels of IL-10 than LPS or vitamin D3-treated DCs. Although these increasing levels of IL-10 were not significant, however, it was significant compared to control. Alternatively, the effect of LPS on IL-12p70 secretion was significantly more pronounced than the effect of all other treatments.
<table-wrap id="Tab7"><label>Table 7</label><caption><p>Levels of IL-10 and IL-12p70 cytokines. DCs cultures supernatant were assessed for cytokines production upon stimulation with different stimulant including BSEO as determined by ELISA technique. Data are collected from five independent experiments</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Treatments</th><th>IL-10&#x02009;pg/mL&#x02009;&#x000b1;&#x02009;SD</th><th>IL-12p70 pg/mL&#x02009;&#x000b1;&#x02009;SD</th></tr></thead><tbody><tr><td>Control</td><td>65.3&#x000a0;&#x000b1;&#x000a0;22.7</td><td>7.4&#x02009;&#x000b1;&#x02009;1.7&#x02022;&#x02022;&#x02022;</td></tr><tr><td>LPS</td><td>254.3&#x000a0;&#x000b1;&#x000a0;153.5 ***</td><td>318.7&#x02009;&#x000b1;&#x02009;70.4</td></tr><tr><td>VIT-D3</td><td>265&#x000a0;&#x000b1;&#x000a0;113.2 ***</td><td>10.4&#x02009;&#x000b1;&#x02009;1.6&#x02022;&#x02022;&#x02022;</td></tr><tr><td>BSEO-5</td><td>257&#x000a0;&#x000b1;&#x000a0;101.5 ***</td><td>8.4&#x02009;&#x000b1;&#x02009;3.7&#x02022;&#x02022;&#x02022;</td></tr><tr><td>BSEO-10</td><td>272.3&#x000a0;&#x000b1;&#x000a0;50.4 ***</td><td>10.1&#x02009;&#x000b1;&#x02009;2.4&#x02022;&#x02022;&#x02022;</td></tr></tbody></table><table-wrap-foot><p>(*) Referred to significant difference compared to the control, where *** (<italic>P</italic> &#x0003c; 0.001)</p><p>(&#x02022;) Referred to significant difference compared to LPS treated cells, where &#x02022;&#x02022;&#x02022; (<italic>P</italic> &#x0003c; 0.001)</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec25"><title>Chemical compositions and their biological activities</title><p id="Par39">GC/MS analysis demonstrates that the highest abundant compounds (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) present in <italic>Boswellia sacra</italic> resin essential oil exhibit several biological activities including antibacterial, antioxidant, anti-inflammatory, antiparasitic, antineoplastic, and apoptosis and inflammatory mediators (Table&#x000a0;<xref rid="Tab8" ref-type="table">8</xref>).
<fig id="Fig3"><label>Fig. 3</label><caption><p>Total ion GC-MS chromatogram of characterized volatile compounds of <italic>Boswellia sacra</italic> resin oil extracted by hydro-distillation</p></caption><graphic xlink:href="12906_2020_3146_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab8"><label>Table 8</label><caption><p>Compounds determined in the oil of <italic>Boswellia sacra</italic> resin extracted by hydro-distillation</p></caption><table frame="hsides" rules="groups"><thead><tr><th>TIME</th><th>Relative %</th><th>Compound name</th><th>Structure</th><th>Biological activity</th></tr></thead><tbody><tr><td>9.14</td><td>4.91</td><td>&#x003b1;-Copaene</td><td><inline-graphic xlink:href="12906_2020_3146_Figa_HTML.gif" id="d30e1657"/></td><td>Anti-inflammatory activities [<xref ref-type="bibr" rid="CR25">25</xref>]</td></tr><tr><td>13.13</td><td>5.33</td><td>(&#x02212;)-&#x003b2;-Elemene</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figb_HTML.gif" id="d30e1678"/></td><td>Anti-cancer and anti-angiogenic activities [<xref ref-type="bibr" rid="CR26">26</xref>]</td></tr><tr><td>14.21</td><td>20.58</td><td>&#x003b2;-Caryophyllene</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figc_HTML.gif" id="d30e1699"/></td><td>Analgesic, anti-inflammatory and anticancer effects [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]</td></tr><tr><td>16.56</td><td>2.04</td><td>4-Terpinenol</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figd_HTML.gif" id="d30e1723"/></td><td>Antibacterial, antioxidant, anti-inflammatory and antineoplastic activity [<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td>16.68</td><td>4.55</td><td>Humulene (&#x003b1;-Caryophyllene)</td><td>
<inline-graphic xlink:href="12906_2020_3146_Fige_HTML.gif" id="d30e1744"/></td><td>Topical and systemic anti-inflammatory properties [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td>16.96</td><td>9.51</td><td>(+)-&#x003b4;-Cadinene</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figf_HTML.gif" id="d30e1768"/></td><td>Anti malarial anti-microbial properties [<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td>17.03</td><td>2.4</td><td>&#x003b1;-Selinene</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figg_HTML.gif" id="d30e1789"/></td><td>Anti-inflammatory, analgesic, and antipyretic activity [<xref ref-type="bibr" rid="CR33">33</xref>]</td></tr><tr><td>17.17</td><td>2.11</td><td>&#x003b3;-Cadinene</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figh_HTML.gif" id="d30e1810"/></td><td>Antioxidant properties [<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td>17.59</td><td>6.39</td><td>&#x003b2;-Cubebene</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figi_HTML.gif" id="d30e1831"/></td><td>Antioxidant and antimicrobial activities [<xref ref-type="bibr" rid="CR35">35</xref>]</td></tr><tr><td>18.49</td><td>2.69</td><td>cis-Verbenol</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figj_HTML.gif" id="d30e1852"/></td><td>Anti-ischemic and anti-inflammatory activity {Choi, 2010 #74}</td></tr><tr><td>26.79</td><td>3.3</td><td>&#x003b3;-Muurolene</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figk_HTML.gif" id="d30e1870"/></td><td>Antimicrobial and anti-inflammatory activities [<xref ref-type="bibr" rid="CR36">36</xref>]</td></tr><tr><td>30.44</td><td>5.2</td><td>L-Elemol</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figl_HTML.gif" id="d30e1892"/></td><td>Anti-inflammatory activities [<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>31.91</td><td>3</td><td>tau-Cadinol</td><td>
<inline-graphic xlink:href="12906_2020_3146_Figm_HTML.gif" id="d30e1913"/></td><td>Antimicrobial activity {Ho, 2011 #68}</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec26"><title>Discussion</title><p id="Par40">Dendritic cells became promising tools involved in immunotherapeutic techniques. Down-regulation of the immune response is needed to mitigate the inflammation associated with DCs, while the upregulation of immune response requires promoting DCs differentiation and maturation. To our knowledge, no precursor data reported the impact of <italic>Boswellia sacra</italic> essential oil (BSEO) on human monocyte-derived DCs as professional antigen-presenting immune cells. Therefore, in this study, we assessed the outcomes of BSEO treatment on human DCs properties. The concentrations of BSEO used were based on the extent of cytotoxicity confirmed by several viability assessments. Phenotypical and functional properties have been also studied using microscopy, flow cytometry, and ELISA.</p><p id="Par41">Crude BSEO is a natural product, which has chemical constituents with potential effects. Some BSEO constituents may induce toxicity to normal cells. For this reason, different concentrations of BSEO was previously tested on HSD cells and monocytes before applying on DCs. Trypan blue exclusion assay indicated that 5&#x02009;&#x003bc;g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL crude BSEO had no toxic effects on normal cells, HSD cells, and monocytes as DC progenitors, compared to control cells. Otherwise, high concentrations of crude BSEO at 15, 20, and 50&#x02009;<italic>&#x003bc;</italic>g/mL reduced the viability of cells in a concentration-dependent manner. Based on the above findings, less toxic concentrations 5&#x02009;<italic>&#x003bc;</italic>g/mL and 10&#x02009;<italic>&#x003bc;</italic>g/mL were used in the following experiments. Similar findings on the impact of BSEO toxicity on normal cells were also reported by [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par42">The ability of crude oil to induce monocyte differentiation into DCs was investigated using the two chosen concentrations. Our results showed that the addition of 5&#x02009;<italic>&#x003bc;</italic>g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL crude BSEO to cultured monocytes did not induce complete differentiation into DCs compared to cytokine differentiated DCs. This was observed by the high expression of CD14, which is identified as a monocyte marker that usually suppressed upon differentiation into DCs. The effect of BSEO on CD14 expression, as a natural product, was also shown with a natural product chrysin, in which its suppression effect on DC differentiation from monocytes [<xref ref-type="bibr" rid="CR38">38</xref>]. In addition, the low expression of CD11c on BSEO stimulated cells compared to control differentiated cells suggested that monocytes remained undifferentiated. In fact, CD11c is an important marker for cell attachment and always remained high on DCs [<xref ref-type="bibr" rid="CR39">39</xref>] and usually low on monocytes.</p><p id="Par43">The cell surface phenotype of DCs is used to determine the developmental and maturational status of DCs, imDCs, or mDCs [<xref ref-type="bibr" rid="CR40">40</xref>]. The upregulation of HLA-DR, CD86, and CD83 expression on DCs is an indication of their maturation [<xref ref-type="bibr" rid="CR41">41</xref>]. Moreover, low levels of CD83 mediate impaired T cells stimulation [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. In our hands, exposure to BSEO in the presence or absence of LPS, reduced significantly the expression of CD83, CD86, and HLA-DR on the surface of DCs, suggesting an immature phenotype of the produced DCs.</p><p id="Par44">The modulation effects of BSEO on DCs maturation were comparable to the modulation of vitamin D3 on DCs, where vitamin D3 is known to block DCs maturation as previously reported [<xref ref-type="bibr" rid="CR44">44</xref>&#x02013;<xref ref-type="bibr" rid="CR46">46</xref>]. It has also been reported the reduction of bone marrow-derived murine DC maturation treated with curcumin in the lack or presence of LPS, and which significantly reduced the expression of CD86 [<xref ref-type="bibr" rid="CR47">47</xref>]. Both costimulatory molecules, CD80 and CD86, contribute to homeostasis and direct the immune response into immunosuppressive or immunostimulatory [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. It is well known that imDCs mediate immune tolerance, and a decrease in the expression of CD86 is a typical marker for a tolerogenic DC phenotype [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. However, CD80 has a higher affinity for CTLA-4 than CD86 and mediates immuno-regulatory responses [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. In the current study, the crude BSEO-stimulated DCs exhibited higher expression of CD80 than had CD86. We can conclude that stimulation of imDCs by crude BSEO may develop semimature or tolerogenic DCs and may mediate immunoregulatory responses. This characteristic was accompanied with lower expression of antigen-presenting molecule HLA-DR as reported by [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par45">Migration of DCs to T cells areas at lymphoid tissues and organs depends on the presence of the chemokine receptor CCR7. This important role of CCR7 in migration has been verified in a knockout mouse model [<xref ref-type="bibr" rid="CR53">53</xref>]. However, other reports have shown that, apart from chemotaxis, CCR7 controls the endocytosis level, survival, and maturation of DCs [<xref ref-type="bibr" rid="CR54">54</xref>]. During maturation, CCR7 is upregulated to guides the migratory DCs to the nodes [<xref ref-type="bibr" rid="CR55">55</xref>]. Independently from maturation, CCR7-expressing imDCs subsets continuously migrate to the lymph nodes to contribute to the peripheral tolerance against self-antigens even in the absence of danger signals [<xref ref-type="bibr" rid="CR56">56</xref>].</p><p id="Par46">The current study has demonstrated that DCs CCR7 expression upon addition of BSEO was significantly lower than that of LPS-stimulated DCs. Taking into account the immature status of the produced DCs, this finding may suggest that BESO-treated DCs has a teloregenic immune response. Although mature DCs use CCR7 to build up an effective adaptive immune response, imDCs use this certain receptor to migrate continuously to induce immune tolerance in lymph nodes [<xref ref-type="bibr" rid="CR6">6</xref>]. The present study has demonstrated that CCR7 expression by BSEO-5 and BSEO-10-stimulated DCs was significantly lower than LPS-stimulated DCs. This suggest low CCR7-mediated migration and partly responsible to reduce the adaptive immune response.</p><p id="Par47">The development of na&#x000ef;ve T cells into effector cells is one of the major functions of DCs to establish the desired response, either immunity or tolerance. In this study, the determination of CD3 and CD71 expressions were used as indicators of T cell proliferation [<xref ref-type="bibr" rid="CR57">57</xref>]. The current results indicated that addition of crude BSEO to DCs after addition of LPS has reduced the concentration of CD3<sup>+</sup>CD71<sup>+</sup> cocultured T-cells that suggest its effect on regulating T-cells proliferation. Furthermore, the current crude BSEO showed an inhibitory effect on the ability of LPS to provoke T cell proliferation, where is similar to the effect of vitamin D3 on T cell response observed in this study. Strong evidence indicated that vitamin D3 induces tolerogenic properties of DCs, which correlate with inhibition of DC maturation, high level of IL-10 secretion, and impaired stimulatory capacity of T cells [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Therefore, this study suggested that BSEO might direct DCs towards tolerogenic ones.</p><p id="Par48">Internalization is a first step required to process and present antigens in an appropriate form to prime the specific immune response [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. It is well known that imDCs are highly endocytic cells compared to mature DCs [<xref ref-type="bibr" rid="CR59">59</xref>]. The immunomodulatory effect of BSEO stimulation on the endocytic capacity of DCs was evaluated after 24&#x02009;h using FITC-dextran uptake and compared to LPS and vitamin D3 treated DCs. Data demonstrated that BSEO (5&#x02009;&#x003bc;g/mL or 10&#x02009;<italic>&#x003bc;</italic>g/mL) increased the endocytic capacity of DCs similarly to vitamin D3-treated DCs.</p><p id="Par49">Endocytic capacity of mannose receptor is strong in imDC differentiated in the presence of GM-CSF and IL-4 [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. While LPS-matured DCs express about 50% low levels of mannose receptor than present on imDCs [<xref ref-type="bibr" rid="CR61">61</xref>]. This was also observed in our results when DCs were treated with LPS and FITC-dextran uptake was decreased.</p><p id="Par50">ImDCs resemble tolerogenic DCs, which promote Treg development mediate with IL-10 production. Whereas, LPS usually induces immunogenic DCs which promote Th1 development mediated by IL-12 production [<xref ref-type="bibr" rid="CR62">62</xref>]. IL-10 production by DCs is crucial for the generation of tolerance that suppresses the production of proinflammatory cytokines such as IL-12 [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Furthermore, L-10-produced DCs have a role in the development of Treg immunity, whereas IL-12-produced DCs correlated to Th1 immunity [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>].</p><p id="Par51">In the present study, cytokine analysis of DCs supernatant after crude BSEO treatment revealed a significant increase in the levels of the anti-inflammatory cytokine IL-10 secretion and reduced levels of inflammatory cytokine IL-12. Since IL-10 cytokine causes a reduction of antigen-presenting and costimulatory molecules on DCs [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>], this may provide a rational for the observed tolerogenic properties of DCs and supports the conclusion that BSEO regulates DCs functions and reinforces a state of immunotolerance.</p><p id="Par52">In accordance to our data, it has been reported that the boswellic acids of <italic>Boswellia serrata</italic> inhibit the regulation of TNF-&#x003b1; in LPS-stimulated monocytes [<xref ref-type="bibr" rid="CR69">69</xref>]. Moreover, the crude methanolic extract of <italic>Boswellia serrata</italic> and its pure component, 12-ursine-2-diketone, inhibited pro-inflammatory mediators such as TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 in cultured human PBMCs [<xref ref-type="bibr" rid="CR70">70</xref>]. Recently, several studies confirmed the therapeutic potential of some Boswellia sp. extracts and their chemical constituents as anti-inflammatory, anti-cancer, and immunomodulatory effects including antimicrobial activity towards antibiotic-resistant bacteria such as <italic>Staphylococcus aureus</italic> [<xref ref-type="bibr" rid="CR71">71</xref>]. Other investigations revealed that the constituents in the oleogum resin from different Boswellia species exhibited cytotoxic efficacy against treatment-resistant human metastatic breast cancer cell line MDA-MB-231 [<xref ref-type="bibr" rid="CR72">72</xref>]. Moreover, the boswellic extracts and 11-keto-&#x000df;-boswellic acid were also reported to suppress the activities of proinflammatory cytokines in type 1 and type 2 diabetes [<xref ref-type="bibr" rid="CR73">73</xref>]. The analgesic activity of Boswellia and its extract has been reported to reduce osteoarthritis patients pain [<xref ref-type="bibr" rid="CR74">74</xref>].</p><p id="Par53">In the present study, we attempted to explore the major chemical components in BESO (Table <xref rid="Tab8" ref-type="table">8</xref>). We found that the highest abundant constituent is &#x003b2;-Caryophyllen, 20% of the BESO, which is a volatile natural bicyclic sesquiterpene that contributes to the aroma of black pepper and found in many essential oils, especially clove oil, <italic>Cannabis sativa</italic>, rosemary, and hops. Due to its resemblance in structure and properties of cannabinoid related molecules, &#x003b2;-Caryophyllen binds to the cannabinoid 2 (CB2) receptor and exerts analgesic, anti-inflammatory and anticancer effects [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. However, it does not bind to centrally expressed cannabinoid receptor type-1 (CB1) or exert psychoactive effects [<xref ref-type="bibr" rid="CR75">75</xref>]. The second abundant compound in BESO is &#x003b4;-cadinene (10%), which is bicyclic sesquiterpenes that occur in a wide variety of essential oil-producing plants. Cadinene is found in several species of cotton and exerts antimalarial activity [<xref ref-type="bibr" rid="CR32">32</xref>]. &#x003b2;-Cubebene constitute 6.5% of the BESO content, which is a tricyclic sesquiterpene, a constituent of the leaf oil cubebene first isolated from <italic>Piper cubeba</italic> berries, known as cubebs and exerts antioxidant and antimicrobial activities [<xref ref-type="bibr" rid="CR35">35</xref>]. &#x003b2;-Elemen and l-Elemol are sesquiterpenoid, where &#x003b2;-Elemen has anticancer and antiangiogenic activities [<xref ref-type="bibr" rid="CR26">26</xref>] and l-elemol play a role as antiinflammatory agents useful against atopic dermatitis [<xref ref-type="bibr" rid="CR37">37</xref>]. &#x003b1;- &#x003b1;-Copaene is a complex, highly volatile, widely distributed plant sesquiterpene specially in Copaifera species that showed marked anti-inflammatory activities [<xref ref-type="bibr" rid="CR25">25</xref>]. The next abundant compound in BESO is Humulene (4.55%), also known as &#x003b1;-Caryophyllene, which is a naturally occurring monocyclic sesquiterpene usually found as a mixture with &#x003b2;-Caryophyllen, and the two are often found together as a mixture in many aromatic plants. It has topical and systemic anti-inflammatory properties [<xref ref-type="bibr" rid="CR30">30</xref>], and is an effective analgesic when taken topically, orally, or by aerosol [<xref ref-type="bibr" rid="CR31">31</xref>]. tau-cadino Tau-cadinol is a cadinane sesquiterpenoid that has a role as an antimicrobial agent [<xref ref-type="bibr" rid="CR76">76</xref>]. (S)-cis-verbenol, a natural metabolite from (&#x02212;)-alpha-pinene of the host pine tree, has been found to have anti-ischemic activity [<xref ref-type="bibr" rid="CR77">77</xref>]. Selinene is another sesquiterpene found in celery seeds that exhibits anti-inflammatory, analgesic, and antipyretic activity [<xref ref-type="bibr" rid="CR33">33</xref>]. (&#x02212;)-&#x003b3;-Cadinene is a sesquiterpene and can be isolated from A. terreus. It has antioxidant properties [<xref ref-type="bibr" rid="CR34">34</xref>]. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), is 1-menthene carrying a hydroxy substituent at position 4. It exhibits several biological activities including antibacterial, antioxidant, anti-inflammatory, antiparasitic, antineoplastic, and apoptosis and inflammatory mediators production [<xref ref-type="bibr" rid="CR29">29</xref>]. The presence of these constituents with mostly antinflammatory confirms our aforementioned in-vitro results.</p></sec><sec id="Sec27"><title>Conclusion</title><p id="Par54">This study focused on the immunomodulatory effects of BSEO on DCs viability, phenotype, and function. Our results showed that BSEO has anti-inflammatory properties mediated by DCs. It was demonstrated that crude BSEO acts as an immune suppressor of human peripheral blood monocyte-derived DCs, which may promote the Treg permissive environment. The suppression effects were evident in terms of differentiation, expression of maturation markers, cytokine production, and inhibition of monocyte-derived DCs stimulated with LPS. Analysis of the chemical composition of BESO revealed the presence of compounds with several biological activities including antibacterial, antioxidant, anti-inflammatory, antiparasitic, antineoplastic, properties that may explain the anti-inflammatory properties of <italic>Boswellia sacra</italic> resin and its oils. Altogether, this study indicates that crude BSEO may be an effective anti-inflammatory agent that requires more investigation to develop a potential therapy for many inflammatory diseases.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>BSEO</term><def><p id="Par5"><italic>Boswellia sacra</italic> essential oil</p></def></def-item><def-item><term>DCs</term><def><p id="Par6">Dendritic cells</p></def></def-item><def-item><term>imDCs</term><def><p id="Par7">Immature DCs</p></def></def-item><def-item><term>mDCs</term><def><p id="Par8">Mature DCs</p></def></def-item><def-item><term>PBMCs</term><def><p id="Par9">Peripheral blood mononuclear cells</p></def></def-item><def-item><term>KFMRC</term><def><p id="Par10">King Fahad Medical Research Center</p></def></def-item><def-item><term>KAU</term><def><p id="Par11">King Abdulaziz University</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors also acknowledge with thanks KFMRC, King Abdulaziz University, for technical support.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>AMA served as principle investigator. AMA and ME contributed to the study design and experimental supervision. ATA carried out the experiments. AMA and ME interpreted data and drafted manuscript. All Authors revised and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This project was funded by King Abdulaziz City for Science and Technology, Saudi Arabia, award no. (PS-35-190). Fund was used for purchasing part of the materials and investigators salaries.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this published article.</p></notes><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par55">Ethical approval was obtained from unit of Biomedical Ethics of Center of Excellence in Genomic Medicine Research Ethics committee, King Abdulaziz University (Approval no: 014-CEGMR-ETH-01).</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par56">&#x0201c;Not applicable&#x0201d;.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par57">The authors declare that they have no competing interests in this section.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannino</surname><given-names>G</given-names></name><name><surname>Occhipinti</surname><given-names>A</given-names></name><name><surname>Maffei</surname><given-names>ME</given-names></name></person-group><article-title>Quantitative Determination of 3-O-Acetyl-11-Keto-&#x003b2;Boswellic Acid (AKBA) and Other Boswellic Acids in <italic>Boswellia sacra</italic> Flueck (syn. <italic>B. carteri</italic> Birdw) and <italic>Boswellia serrata</italic> Roxb</article-title><source>Molecules.</source><year>2016</year><volume>21</volume><issue>10</issue><fpage>1329</fpage><pub-id pub-id-type="doi">10.3390/molecules21101329</pub-id><?supplied-pmid 6273064?><pub-id pub-id-type="pmid">6273064</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Efferth T, Oesch F. Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities. Semin Cancer Biol. 2020:S1044-579X(20)30034-1 10.1016/j.semcancer.2020.01.015.</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Khanna</surname><given-names>S</given-names></name><name><surname>Krishnaraju</surname><given-names>AV</given-names></name><name><surname>Subbaraju</surname><given-names>GV</given-names></name><name><surname>Yasmin</surname><given-names>T</given-names></name><name><surname>Bagchi</surname><given-names>D</given-names></name><name><surname>Sen</surname><given-names>CK</given-names></name></person-group><article-title>Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia</article-title><source>Antioxid Redox Signal.</source><year>2006</year><volume>8</volume><issue>3-4</issue><fpage>653</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1089/ars.2006.8.653</pub-id><?supplied-pmid 16677108?><pub-id pub-id-type="pmid">16677108</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname><given-names>KSR</given-names></name><name><surname>Reddy</surname><given-names>MC</given-names></name><name><surname>Rani</surname><given-names>SS</given-names></name><name><surname>Pullaiah</surname><given-names>T</given-names></name></person-group><article-title>Bioactive principles and biological properties of essential oils of Burseraceae: a review</article-title><source>J Pharmacognosy Phytochemistry</source><year>2016</year><volume>5</volume><issue>2</issue><fpage>247</fpage></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Jakubzick</surname><given-names>C</given-names></name><name><surname>Naik</surname><given-names>SH</given-names></name><name><surname>Onai</surname><given-names>N</given-names></name><name><surname>Schraml</surname><given-names>BU</given-names></name><name><surname>Segura</surname><given-names>E</given-names></name><name><surname>Tussiwand</surname><given-names>R</given-names></name><name><surname>Yona</surname><given-names>S</given-names></name></person-group><article-title>Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny</article-title><source>Nat Rev Immunol.</source><year>2014</year><volume>14</volume><issue>8</issue><fpage>571</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1038/nri3712</pub-id><?supplied-pmid 25033907?><pub-id pub-id-type="pmid">25033907</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>IV</given-names></name></person-group><source>In vitro generation of human monocyte-derived dendritic cells within 48 hours: lmu</source><year>2012</year></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadhasivam</surname><given-names>S</given-names></name><name><surname>Palanivel</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name></person-group><article-title>Synergistic antimicrobial activity of Boswellia serrata Roxb. Ex Colebr.(Burseraceae) essential oil with various azoles against pathogens associated with skin, scalp and nail infections</article-title><source>Lett Appl Microbiol.</source><year>2016</year><volume>63</volume><issue>6</issue><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1111/lam.12683</pub-id><?supplied-pmid 27730658?><pub-id pub-id-type="pmid">27730658</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>D</given-names></name><name><surname>Lou</surname><given-names>W</given-names></name><name><surname>Fung</surname><given-names>KM</given-names></name><name><surname>Wolley</surname><given-names>CL</given-names></name><name><surname>Suhail</surname><given-names>MM</given-names></name><name><surname>Lin</surname><given-names>HK</given-names></name></person-group><article-title>Cancer Chemopreventive Effects of Boswellia sacra Gum Resin Hydrodistillates on Invasive Urothelial Cell Carcinoma: Report of a Case</article-title><source>Integr Cancer Ther.</source><year>2017</year><volume>16</volume><issue>4</issue><fpage>605</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1177/1534735416664174</pub-id><?supplied-pmid 27531547?><pub-id pub-id-type="pmid">27531547</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurokawa</surname><given-names>K</given-names></name><name><surname>Ishii</surname><given-names>T</given-names></name><name><surname>An</surname><given-names>W-W</given-names></name><name><surname>Kanazawa</surname><given-names>Y</given-names></name><name><surname>Ozawa</surname><given-names>M</given-names></name><name><surname>Ichiyanagi</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Nishihara</surname><given-names>E</given-names></name></person-group><article-title>Nakaya K. A heat-stable extract from mucuna stimulates the differentiation of bone marrow cells into dendritic cells and induces apoptosis in cancer cells</article-title><source>Nutr Cancer.</source><year>2011</year><volume>63</volume><issue>1</issue><fpage>100</fpage><lpage>108</lpage><?supplied-pmid 21170811?><pub-id pub-id-type="pmid">21170811</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amirghofran</surname><given-names>Z</given-names></name><name><surname>Ahmadi</surname><given-names>H</given-names></name><name><surname>Karimi</surname><given-names>MH</given-names></name></person-group><article-title>Immunomodulatory activity of the water extract of Thymus vulgaris, Thymus daenensis, and Zataria multiflora on dendritic cells and T cells responses</article-title><source>J Immunoass Immunochem.</source><year>2012</year><volume>33</volume><issue>4</issue><fpage>388</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1080/15321819.2012.655822</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y-R</given-names></name><name><surname>Chen</surname><given-names>D-Y</given-names></name><name><surname>Chu</surname><given-names>C-L</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y-K</given-names></name><name><surname>Wu</surname><given-names>C-L</given-names></name><name><surname>Lin</surname><given-names>C-C</given-names></name></person-group><article-title>Naringenin inhibits dendritic cell maturation and has therapeutic effects in a murine model of collagen-induced arthritis</article-title><source>J Nutr Biochem.</source><year>2015</year><volume>26</volume><issue>12</issue><fpage>1467</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2015.07.016</pub-id><?supplied-pmid 26350255?><pub-id pub-id-type="pmid">26350255</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>W-W</given-names></name><name><surname>Kanazawa</surname><given-names>Y</given-names></name><name><surname>Ozawa</surname><given-names>M</given-names></name><name><surname>Nakaya</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>A</given-names></name><name><surname>Bradley</surname><given-names>WG</given-names></name></person-group><article-title>Dendritic cell differentiation and tumor cell apoptosis induced by components of a poly-phenylpropanoid polysaccharide complex</article-title><source>Anticancer Res.</source><year>2010</year><volume>30</volume><issue>2</issue><fpage>613</fpage><lpage>622</lpage><?supplied-pmid 20332479?><pub-id pub-id-type="pmid">20332479</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakaya</surname><given-names>K</given-names></name><name><surname>Nabata</surname><given-names>Y</given-names></name><name><surname>Ichiyanagi</surname><given-names>T</given-names></name><name><surname>An</surname><given-names>WW</given-names></name></person-group><article-title>Stimulation of dendritic cell maturation and induction of apoptosis in leukemia cells by a heat-stable extract from azuki bean (Vigna angularis), a promising immunopotentiating food and dietary supplement for cancer prevention</article-title><source>Asian Pac J Cancer Prev.</source><year>2012</year><volume>13</volume><issue>2</issue><fpage>607</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.7314/APJCP.2012.13.2.607</pub-id><?supplied-pmid 22524832?><pub-id pub-id-type="pmid">22524832</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name></person-group><article-title>The immunoregulatory effects of Chinese herbal medicine on the maturation and function of dendritic cells</article-title><source>J Ethnopharmacol.</source><year>2015</year><volume>171</volume><fpage>184</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.05.050</pub-id><?supplied-pmid 26068430?><pub-id pub-id-type="pmid">26068430</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhail</surname><given-names>MM</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>A</given-names></name><name><surname>Mondalek</surname><given-names>FG</given-names></name><name><surname>Fung</surname><given-names>K-M</given-names></name><name><surname>Shih</surname><given-names>P-T</given-names></name><name><surname>Fang</surname><given-names>Y-T</given-names></name><name><surname>Woolley</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>H-K</given-names></name></person-group><article-title>Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells</article-title><source>BMC Complement Altern Med.</source><year>2011</year><volume>11</volume><issue>1</issue><fpage>129</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-11-129</pub-id><?supplied-pmid 22171782?><pub-id pub-id-type="pmid">22171782</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahassni</surname><given-names>SH</given-names></name><name><surname>Al-Reemi</surname><given-names>RM</given-names></name></person-group><article-title>Apoptosis and necrosis of human breast cancer cells by an aqueous extract of garden cress (Lepidium sativum) seeds</article-title><source>Saudi J Biol Sci.</source><year>2013</year><volume>20</volume><issue>2</issue><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2012.12.002</pub-id><?supplied-pmid 23961228?><pub-id pub-id-type="pmid">23961228</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romani</surname><given-names>N</given-names></name><name><surname>Gruner</surname><given-names>S</given-names></name><name><surname>Brang</surname><given-names>D</given-names></name><name><surname>K&#x000e4;mpgen</surname><given-names>E</given-names></name><name><surname>Lenz</surname><given-names>A</given-names></name><name><surname>Trockenbacher</surname><given-names>B</given-names></name><name><surname>Konwalinka</surname><given-names>G</given-names></name><name><surname>Fritsch</surname><given-names>PO</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name><name><surname>Schuler</surname><given-names>G</given-names></name></person-group><article-title>Proliferating dendritic cell progenitors in human blood</article-title><source>J Exp Med.</source><year>1994</year><volume>180</volume><issue>1</issue><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1084/jem.180.1.83</pub-id><?supplied-pmid 8006603?><pub-id pub-id-type="pmid">8006603</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delles</surname><given-names>AM</given-names></name><name><surname>Rittenhouse-Olson</surname><given-names>K</given-names></name><name><surname>Morgan</surname><given-names>J</given-names></name><name><surname>Oseroff</surname><given-names>AR</given-names></name></person-group><article-title>A simple method for the purification of human peripheral blood antigen presenting cells (dendritic cells, monocytes/macrophages, and B lymphocytes)</article-title><source>Immunol Investig.</source><year>2002</year><volume>31</volume><issue>3&#x02013;4</issue><fpage>233</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1081/IMM-120016243</pub-id><pub-id pub-id-type="pmid">12472182</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romani</surname><given-names>N</given-names></name><name><surname>Reider</surname><given-names>D</given-names></name><name><surname>Heuer</surname><given-names>M</given-names></name><name><surname>Ebner</surname><given-names>S</given-names></name><name><surname>Kampgen</surname><given-names>E</given-names></name><name><surname>Eibl</surname><given-names>B</given-names></name><name><surname>Niederwieser</surname><given-names>D</given-names></name><name><surname>Schuler</surname><given-names>G</given-names></name></person-group><article-title>Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability</article-title><source>J Immunol Methods.</source><year>1996</year><volume>196</volume><issue>2</issue><fpage>137</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(96)00078-6</pub-id><?supplied-pmid 8841452?><pub-id pub-id-type="pmid">8841452</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>SA</given-names></name><name><surname>Elshal</surname><given-names>MF</given-names></name><name><surname>Kumosani</surname><given-names>TA</given-names></name><name><surname>Aldahlawi</surname><given-names>AM</given-names></name><name><surname>Basbrain</surname><given-names>TA</given-names></name><name><surname>Alshehri</surname><given-names>FA</given-names></name><name><surname>Choudhry</surname><given-names>H</given-names></name></person-group><article-title>L-asparaginase isolated from phaseolus vulgaris seeds exhibited potent anti-acute lymphoblastic leukemia effects in-vitro and low immunogenic properties in-vivo</article-title><source>Int J Environ Res Public Health.</source><year>2016</year><volume>13</volume><issue>10</issue><fpage>1008</fpage><pub-id pub-id-type="doi">10.3390/ijerph13101008</pub-id><?supplied-pmid 5086747?><pub-id pub-id-type="pmid">5086747</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egner</surname><given-names>W</given-names></name><name><surname>McKenzie</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Beard</surname><given-names>M</given-names></name><name><surname>Hart</surname><given-names>D</given-names></name></person-group><article-title>Identification of potent mixed leukocyte reaction-stimulatory cells in human bone marrow. Putative differentiation stage of human blood dendritic cells</article-title><source>J Immunol.</source><year>1993</year><volume>150</volume><issue>7</issue><fpage>3043</fpage><lpage>3053</lpage><?supplied-pmid 8454872?><pub-id pub-id-type="pmid">8454872</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piemonti</surname><given-names>L</given-names></name><name><surname>Monti</surname><given-names>P</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name><name><surname>Leone</surname><given-names>BE</given-names></name><name><surname>Caputo</surname><given-names>A</given-names></name><name><surname>Di Carlo</surname><given-names>V</given-names></name></person-group><article-title>Glucocorticoids increase the endocytic activity of human dendritic cells</article-title><source>Int Immunol.</source><year>1999</year><volume>11</volume><issue>9</issue><fpage>1519</fpage><lpage>1526</lpage><pub-id pub-id-type="doi">10.1093/intimm/11.9.1519</pub-id><?supplied-pmid 10464173?><pub-id pub-id-type="pmid">10464173</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>F</given-names></name><name><surname>Stanzl</surname><given-names>U</given-names></name><name><surname>Jennewein</surname><given-names>P</given-names></name><name><surname>Janke</surname><given-names>K</given-names></name><name><surname>Heufler</surname><given-names>C</given-names></name><name><surname>Kampgen</surname><given-names>E</given-names></name><name><surname>Romani</surname><given-names>N</given-names></name><name><surname>Schuler</surname><given-names>G</given-names></name></person-group><article-title>High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10</article-title><source>J Exp Med.</source><year>1996</year><volume>184</volume><issue>2</issue><fpage>741</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1084/jem.184.2.741</pub-id><?supplied-pmid 8760828?><pub-id pub-id-type="pmid">8760828</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>X</given-names></name><name><surname>Suhail</surname><given-names>MM</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Cao</surname><given-names>A</given-names></name><name><surname>Fung</surname><given-names>K-M</given-names></name><name><surname>Postier</surname><given-names>RG</given-names></name><name><surname>Woolley</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>H-K</given-names></name></person-group><article-title>Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model</article-title><source>BMC Complement Altern Med.</source><year>2012</year><volume>12</volume><issue>1</issue><fpage>253</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-12-253</pub-id><?supplied-pmid 23237355?><pub-id pub-id-type="pmid">23237355</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basile</surname><given-names>AC</given-names></name><name><surname>Sertie</surname><given-names>JA</given-names></name><name><surname>Freitas</surname><given-names>PC</given-names></name><name><surname>Zanini</surname><given-names>AC</given-names></name></person-group><article-title>Anti-inflammatory activity of oleoresin from Brazilian Copaifera</article-title><source>J Ethnopharmacol.</source><year>1988</year><volume>22</volume><issue>1</issue><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(88)90235-8</pub-id><?supplied-pmid 3352280?><pub-id pub-id-type="pmid">3352280</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name></person-group><article-title>Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis</article-title><source>Cancer Chemother Pharmacol.</source><year>2011</year><volume>67</volume><issue>4</issue><fpage>799</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1007/s00280-010-1378-x</pub-id><?supplied-pmid 20563582?><pub-id pub-id-type="pmid">20563582</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Picciolo G, Pallio G, Altavilla D, Vaccaro M, Oteri G, Irrera N, Squadrito F. beta-Caryophyllene Reduces the Inflammatory Phenotype of Periodontal Cells by Targeting CB2 Receptors. Biomedicines. 2020;8(6).</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fidyt</surname><given-names>K</given-names></name><name><surname>Fiedorowicz</surname><given-names>A</given-names></name><name><surname>Strz&#x00105;da&#x00142;a</surname><given-names>L</given-names></name><name><surname>Szumny</surname><given-names>A</given-names></name></person-group><article-title>&#x003b2;-Caryophyllene and &#x003b2;-caryophyllene oxide&#x02014;natural compounds of anticancer and analgesic properties</article-title><source>Cancer Med.</source><year>2016</year><volume>5</volume><issue>10</issue><fpage>3007</fpage><lpage>3017</lpage><pub-id pub-id-type="doi">10.1002/cam4.816</pub-id><?supplied-pmid 27696789?><pub-id pub-id-type="pmid">27696789</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>PH</given-names></name><name><surname>Brand</surname><given-names>C</given-names></name><name><surname>Carson</surname><given-names>CF</given-names></name><name><surname>Riley</surname><given-names>TV</given-names></name><name><surname>Prager</surname><given-names>RH</given-names></name><name><surname>Finlay-Jones</surname><given-names>JJ</given-names></name></person-group><article-title>Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes</article-title><source>Inflamm Res.</source><year>2000</year><volume>49</volume><issue>11</issue><fpage>619</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1007/s000110050639</pub-id><?supplied-pmid 11131302?><pub-id pub-id-type="pmid">11131302</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George Kallivalappil</surname><given-names>G</given-names></name><name><surname>Kuttan</surname><given-names>G</given-names></name></person-group><article-title>Evaluation of the anti-inflammatory and urotoxicity ameliorative effects of gamma-humulene containing active fraction of Emilia sonchifolia (L.) DC</article-title><source>Inflammopharmacology.</source><year>2019</year><volume>27</volume><issue>2</issue><fpage>409</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1007/s10787-017-0423-3</pub-id><?supplied-pmid 29224178?><pub-id pub-id-type="pmid">29224178</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogerio</surname><given-names>AP</given-names></name><name><surname>Andrade</surname><given-names>EL</given-names></name><name><surname>Leite</surname><given-names>DF</given-names></name><name><surname>Figueiredo</surname><given-names>CP</given-names></name><name><surname>Calixto</surname><given-names>JB</given-names></name></person-group><article-title>Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation</article-title><source>Br J Pharmacol.</source><year>2009</year><volume>158</volume><issue>4</issue><fpage>1074</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00177.x</pub-id><?supplied-pmid 19438512?><pub-id pub-id-type="pmid">19438512</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afoulous</surname><given-names>S</given-names></name><name><surname>Ferhout</surname><given-names>H</given-names></name><name><surname>Raoelison</surname><given-names>EG</given-names></name><name><surname>Valentin</surname><given-names>A</given-names></name><name><surname>Moukarzel</surname><given-names>B</given-names></name><name><surname>Couderc</surname><given-names>F</given-names></name><name><surname>Bouajila</surname><given-names>J</given-names></name></person-group><article-title>Chemical composition and anticancer, antiinflammatory, antioxidant and antimalarial activities of leaves essential oil of Cedrelopsis grevei</article-title><source>Food Chem Toxicol.</source><year>2013</year><volume>56</volume><fpage>352</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2013.02.008</pub-id><?supplied-pmid 23459148?><pub-id pub-id-type="pmid">23459148</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>M</given-names></name><name><surname>Prakash</surname><given-names>O</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Bachheti</surname><given-names>RK</given-names></name><name><surname>Bhushan</surname><given-names>B</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Pant</surname><given-names>AK</given-names></name></person-group><article-title>&#x003b2;-Selinene-rich essential oils from the parts of Callicarpa macrophylla and their antioxidant and pharmacological activities</article-title><source>Medicines.</source><year>2017</year><volume>4</volume><issue>3</issue><fpage>52</fpage><pub-id pub-id-type="doi">10.3390/medicines4030052</pub-id><?supplied-pmid 5622387?><pub-id pub-id-type="pmid">5622387</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cane</surname><given-names>DE</given-names></name><name><surname>Rawlings</surname><given-names>BJ</given-names></name><name><surname>Yang</surname><given-names>CC</given-names></name></person-group><article-title>Isolation of (&#x02212;)-gamma-cadinene and aristolochene from Aspergillus terreus</article-title><source>J Antibiot (Tokyo).</source><year>1987</year><volume>40</volume><issue>9</issue><fpage>1331</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.40.1331</pub-id><pub-id pub-id-type="pmid">3680043</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boligon</surname><given-names>AA</given-names></name><name><surname>Piana</surname><given-names>M</given-names></name><name><surname>Brum</surname><given-names>TF</given-names></name><name><surname>Froeder</surname><given-names>AL</given-names></name><name><surname>Belke</surname><given-names>BV</given-names></name><name><surname>Schwanz</surname><given-names>TG</given-names></name><name><surname>Mario</surname><given-names>DN</given-names></name><name><surname>Alves</surname><given-names>SH</given-names></name><name><surname>Athayde</surname><given-names>ML</given-names></name></person-group><article-title>Scutia buxifolia Reissek essential oil: in vitro antioxidant and antimicrobial activities</article-title><source>An Acad Bras Cienc.</source><year>2014</year><volume>86</volume><issue>3</issue><fpage>1463</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1590/0001-3765201420120034</pub-id><?supplied-pmid 25211114?><pub-id pub-id-type="pmid">25211114</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darwish</surname><given-names>RS</given-names></name><name><surname>Hammoda</surname><given-names>HM</given-names></name><name><surname>Ghareeb</surname><given-names>DA</given-names></name><name><surname>Abdelhamid</surname><given-names>ASA</given-names></name><name><surname>EM</surname><given-names>BELN</given-names></name><name><surname>Harraz</surname><given-names>FM</given-names></name><name><surname>Shawky</surname><given-names>E</given-names></name></person-group><article-title>Efficacy-directed discrimination of the essential oils of three Juniperus species based on their in-vitro antimicrobial and anti-inflammatory activities</article-title><source>J Ethnopharmacol.</source><year>2020</year><volume>259</volume><fpage>112971</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2020.112971</pub-id><?supplied-pmid 32439404?><pub-id pub-id-type="pmid">32439404</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Jung</surname><given-names>EM</given-names></name><name><surname>Ahn</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>GS</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>IG</given-names></name><name><surname>Park</surname><given-names>MJ</given-names></name><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Choi</surname><given-names>DH</given-names></name><etal/></person-group><article-title>Elemol from Chamaecyparis obtusa ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis</article-title><source>Int J Mol Med.</source><year>2015</year><volume>36</volume><issue>2</issue><fpage>463</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2015.2228</pub-id><?supplied-pmid 26035417?><pub-id pub-id-type="pmid">26035417</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Ge</surname><given-names>Z</given-names></name><name><surname>Xue</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Mei</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>Chrysin suppresses human CD14+ monocyte-derived dendritic cells and ameliorates experimental autoimmune encephalomyelitis</article-title><source>J Neuroimmunol.</source><year>2015</year><volume>288</volume><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2015.08.017</pub-id><?supplied-pmid 26531689?><pub-id pub-id-type="pmid">26531689</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirley</surname><given-names>SA</given-names></name><name><surname>Montpetit</surname><given-names>AJ</given-names></name><name><surname>Lockey</surname><given-names>R</given-names></name><name><surname>Mohapatra</surname><given-names>SS</given-names></name></person-group><article-title>Curcumin prevents human dendritic cell response to immune stimulants</article-title><source>Biochem Biophys Res Commun.</source><year>2008</year><volume>374</volume><issue>3</issue><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.07.051</pub-id><?supplied-pmid 18639521?><pub-id pub-id-type="pmid">18639521</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribas</surname><given-names>A</given-names></name><name><surname>Glaspy</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Dissette</surname><given-names>VB</given-names></name><name><surname>Seja</surname><given-names>E</given-names></name><name><surname>Vu</surname><given-names>HT</given-names></name><name><surname>Tchekmedyian</surname><given-names>NS</given-names></name><name><surname>Oseguera</surname><given-names>D</given-names></name><name><surname>Comin-Anduix</surname><given-names>B</given-names></name><name><surname>Wargo</surname><given-names>JA</given-names></name></person-group><article-title>Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy</article-title><source>J Immunother.</source><year>2004</year><volume>27</volume><issue>5</issue><fpage>354</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1097/00002371-200409000-00004</pub-id><?supplied-pmid 15314544?><pub-id pub-id-type="pmid">15314544</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tze</surname><given-names>LE</given-names></name><name><surname>Horikawa</surname><given-names>K</given-names></name><name><surname>Domaschenz</surname><given-names>H</given-names></name><name><surname>Howard</surname><given-names>DR</given-names></name><name><surname>Roots</surname><given-names>CM</given-names></name><name><surname>Rigby</surname><given-names>RJ</given-names></name><name><surname>Way</surname><given-names>DA</given-names></name><name><surname>Ohmura-Hoshino</surname><given-names>M</given-names></name><name><surname>Ishido</surname><given-names>S</given-names></name><name><surname>Andoniou</surname><given-names>CE</given-names></name></person-group><article-title>CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10&#x02013;driven MARCH1-mediated ubiquitination and degradation</article-title><source>J Exp Med.</source><year>2011</year><volume>208</volume><issue>1</issue><fpage>149</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1084/jem.20092203</pub-id><?supplied-pmid 21220452?><pub-id pub-id-type="pmid">21220452</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruse</surname><given-names>M</given-names></name><name><surname>Rosorius</surname><given-names>O</given-names></name><name><surname>Kr&#x000e4;tzer</surname><given-names>F</given-names></name><name><surname>Stelz</surname><given-names>G</given-names></name><name><surname>Kuhnt</surname><given-names>C</given-names></name><name><surname>Schuler</surname><given-names>G</given-names></name><name><surname>Hauber</surname><given-names>J</given-names></name><name><surname>Steinkasserer</surname><given-names>A</given-names></name></person-group><article-title>Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity</article-title><source>J Virol.</source><year>2000</year><volume>74</volume><issue>15</issue><fpage>7127</fpage><lpage>7136</lpage><pub-id pub-id-type="doi">10.1128/JVI.74.15.7127-7136.2000</pub-id><?supplied-pmid 10888653?><pub-id pub-id-type="pmid">10888653</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prechtel</surname><given-names>AT</given-names></name><name><surname>Turza</surname><given-names>NM</given-names></name><name><surname>Theodoridis</surname><given-names>AA</given-names></name><name><surname>Steinkasserer</surname><given-names>A</given-names></name></person-group><article-title>CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation</article-title><source>J Immunol.</source><year>2007</year><volume>178</volume><issue>9</issue><fpage>5454</fpage><lpage>5464</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.9.5454</pub-id><?supplied-pmid 17442926?><pub-id pub-id-type="pmid">17442926</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>MD</given-names></name><name><surname>Lutz</surname><given-names>WH</given-names></name><name><surname>Phan</surname><given-names>VA</given-names></name><name><surname>Bachman</surname><given-names>LA</given-names></name><name><surname>McKean</surname><given-names>DJ</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name></person-group><article-title>Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs</article-title><source>Biochem Biophys Res Commun.</source><year>2000</year><volume>270</volume><issue>3</issue><fpage>701</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2000.2490</pub-id><?supplied-pmid 10772887?><pub-id pub-id-type="pmid">10772887</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piemonti</surname><given-names>L</given-names></name><name><surname>Monti</surname><given-names>P</given-names></name><name><surname>Sironi</surname><given-names>M</given-names></name><name><surname>Fraticelli</surname><given-names>P</given-names></name><name><surname>Leone</surname><given-names>BE</given-names></name><name><surname>Dal Cin</surname><given-names>E</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name><name><surname>Di Carlo</surname><given-names>V</given-names></name></person-group><article-title>Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells</article-title><source>J Immunol.</source><year>2000</year><volume>164</volume><issue>9</issue><fpage>4443</fpage><lpage>4451</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.164.9.4443</pub-id><?supplied-pmid 10779743?><pub-id pub-id-type="pmid">10779743</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>N</given-names></name><name><surname>Maldonado</surname><given-names>ML</given-names></name><name><surname>Bachman</surname><given-names>LA</given-names></name><name><surname>McKean</surname><given-names>DJ</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Griffin</surname><given-names>MD</given-names></name></person-group><article-title>Distinctive dendritic cell modulation by vitamin D 3 and glucocorticoid pathways</article-title><source>Biochem Biophys Res Commun.</source><year>2002</year><volume>297</volume><issue>3</issue><fpage>645</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1016/S0006-291X(02)02262-3</pub-id><?supplied-pmid 12270143?><pub-id pub-id-type="pmid">12270143</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>G-Y</given-names></name><name><surname>Kim</surname><given-names>K-H</given-names></name><name><surname>Lee</surname><given-names>S-H</given-names></name><name><surname>Yoon</surname><given-names>M-S</given-names></name><name><surname>Lee</surname><given-names>H-J</given-names></name><name><surname>Moon</surname><given-names>D-O</given-names></name><name><surname>Lee</surname><given-names>C-M</given-names></name><name><surname>Ahn</surname><given-names>S-C</given-names></name><name><surname>Park</surname><given-names>YC</given-names></name><name><surname>Park</surname><given-names>Y-M</given-names></name></person-group><article-title>Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-&#x003ba;B as potential targets</article-title><source>J Immunol.</source><year>2005</year><volume>174</volume><issue>12</issue><fpage>8116</fpage><lpage>8124</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.12.8116</pub-id><pub-id pub-id-type="pmid">15944320</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>KF</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells</article-title><source>Cancer Res.</source><year>2002</year><volume>62</volume><issue>12</issue><fpage>3459</fpage><lpage>3465</lpage><?supplied-pmid 12067989?><pub-id pub-id-type="pmid">12067989</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bak</surname><given-names>SP</given-names></name><name><surname>Barnkob</surname><given-names>MS</given-names></name><name><surname>Bai</surname><given-names>A</given-names></name><name><surname>Higham</surname><given-names>EM</given-names></name><name><surname>Wittrup</surname><given-names>KD</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells</article-title><source>J Immunol.</source><year>2012</year><volume>189</volume><issue>4</issue><fpage>1708</fpage><lpage>1716</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1201271</pub-id><?supplied-pmid 22798683?><pub-id pub-id-type="pmid">22798683</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Manzotti</surname><given-names>CN</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Burke</surname><given-names>F</given-names></name><name><surname>Mead</surname><given-names>KI</given-names></name><name><surname>Sansom</surname><given-names>DM</given-names></name></person-group><article-title>CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells</article-title><source>J Immunol.</source><year>2004</year><volume>172</volume><issue>5</issue><fpage>2778</fpage><lpage>2784</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.5.2778</pub-id><?supplied-pmid 14978077?><pub-id pub-id-type="pmid">14978077</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xuan</surname><given-names>NT</given-names></name><name><surname>Shumilina</surname><given-names>E</given-names></name><name><surname>Nasir</surname><given-names>O</given-names></name><name><surname>Bobbala</surname><given-names>D</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>F</given-names></name><name><surname>Lang</surname><given-names>F</given-names></name></person-group><article-title>Stimulation of mouse dendritic cells by gum Arabic</article-title><source>Cell Physiol Biochem.</source><year>2010</year><volume>25</volume><issue>6</issue><fpage>641</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1159/000315083</pub-id><?supplied-pmid 20511709?><pub-id pub-id-type="pmid">20511709</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>AV</given-names></name><name><surname>Brodie</surname><given-names>DW</given-names></name><name><surname>Gilbert</surname><given-names>RJ</given-names></name><name><surname>Iaboni</surname><given-names>A</given-names></name><name><surname>Manso-Sancho</surname><given-names>R</given-names></name><name><surname>Walse</surname><given-names>B</given-names></name><name><surname>Stuart</surname><given-names>DI</given-names></name><name><surname>van der Merwe</surname><given-names>PA</given-names></name><name><surname>Davis</surname><given-names>SJ</given-names></name></person-group><article-title>The interaction properties of costimulatory molecules revisited</article-title><source>Immunity.</source><year>2002</year><volume>17</volume><issue>2</issue><fpage>201</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00362-X</pub-id><?supplied-pmid 12196291?><pub-id pub-id-type="pmid">12196291</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunn</surname><given-names>MD</given-names></name><name><surname>Kyuwa</surname><given-names>S</given-names></name><name><surname>Tam</surname><given-names>C</given-names></name><name><surname>Kakiuchi</surname><given-names>T</given-names></name><name><surname>Matsuzawa</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>LT</given-names></name><name><surname>Nakano</surname><given-names>H</given-names></name></person-group><article-title>Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization</article-title><source>J Exp Med.</source><year>1999</year><volume>189</volume><issue>3</issue><fpage>451</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1084/jem.189.3.451</pub-id><?supplied-pmid 9927507?><pub-id pub-id-type="pmid">9927507</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Sanchez</surname><given-names>N</given-names></name><name><surname>Riol-Blanco</surname><given-names>L</given-names></name><name><surname>Rodriguez-Fernandez</surname><given-names>JL</given-names></name></person-group><article-title>The multiple personalities of the chemokine receptor CCR7 in dendritic cells</article-title><source>J Immunol.</source><year>2006</year><volume>176</volume><issue>9</issue><fpage>5153</fpage><lpage>5159</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.176.9.5153</pub-id><?supplied-pmid 16621978?><pub-id pub-id-type="pmid">16621978</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randolph</surname><given-names>GJ</given-names></name><name><surname>Angeli</surname><given-names>V</given-names></name><name><surname>Swartz</surname><given-names>MA</given-names></name></person-group><article-title>Dendritic-cell trafficking to lymph nodes through lymphatic vessels</article-title><source>Nat Rev Immunol.</source><year>2005</year><volume>5</volume><issue>8</issue><fpage>617</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1038/nri1670</pub-id><?supplied-pmid 16056255?><pub-id pub-id-type="pmid">16056255</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohl</surname><given-names>L</given-names></name><name><surname>Mohaupt</surname><given-names>M</given-names></name><name><surname>Czeloth</surname><given-names>N</given-names></name><name><surname>Hintzen</surname><given-names>G</given-names></name><name><surname>Kiafard</surname><given-names>Z</given-names></name><name><surname>Zwirner</surname><given-names>J</given-names></name><name><surname>Blankenstein</surname><given-names>T</given-names></name><name><surname>Henning</surname><given-names>G</given-names></name><name><surname>Forster</surname><given-names>R</given-names></name></person-group><article-title>CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions</article-title><source>Immunity.</source><year>2004</year><volume>21</volume><issue>2</issue><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.06.014</pub-id><?supplied-pmid 15308107?><pub-id pub-id-type="pmid">15308107</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motamedi</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Elahi</surname><given-names>S</given-names></name></person-group><article-title>Correlation of transferrin receptor (CD71) with Ki67 expression on stimulated human and mouse T cells: the kinetics of expression of T cell activation markers</article-title><source>J Immunol Methods.</source><year>2016</year><volume>437</volume><fpage>43</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.jim.2016.08.002</pub-id><?supplied-pmid 27555239?><pub-id pub-id-type="pmid">27555239</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Bella</surname><given-names>S</given-names></name><name><surname>Gennaro</surname><given-names>M</given-names></name><name><surname>Vaccari</surname><given-names>M</given-names></name><name><surname>Ferraris</surname><given-names>C</given-names></name><name><surname>Nicola</surname><given-names>S</given-names></name><name><surname>Riva</surname><given-names>A</given-names></name><name><surname>Clerici</surname><given-names>M</given-names></name><name><surname>Greco</surname><given-names>M</given-names></name><name><surname>Villa</surname><given-names>M</given-names></name></person-group><article-title>Altered maturation of peripheral blood dendritic cells in patients with breast cancer</article-title><source>Br J Cancer.</source><year>2003</year><volume>89</volume><issue>8</issue><fpage>1463</fpage><lpage>1472</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6601243</pub-id><?supplied-pmid 14562018?><pub-id pub-id-type="pmid">14562018</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zapala</surname><given-names>L</given-names></name><name><surname>Drela</surname><given-names>N</given-names></name><name><surname>Bil</surname><given-names>J</given-names></name><name><surname>Nowis</surname><given-names>D</given-names></name><name><surname>Basak</surname><given-names>GW</given-names></name><name><surname>Lasek</surname><given-names>W</given-names></name></person-group><article-title>Optimization of activation requirements of immature mouse dendritic JAWSII cells for in vivo application</article-title><source>Oncol Rep.</source><year>2011</year><volume>25</volume><issue>3</issue><fpage>831</fpage><lpage>840</lpage><?supplied-pmid 21206981?><pub-id pub-id-type="pmid">21206981</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quah</surname><given-names>B</given-names></name><name><surname>Ni</surname><given-names>K</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>HC</given-names></name></person-group><article-title>In vitro hematopoiesis produces a distinct class of immature dendritic cells from spleen progenitors with limited T cell stimulation capacity</article-title><source>Int Immunol.</source><year>2004</year><volume>16</volume><issue>4</issue><fpage>567</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxh060</pub-id><?supplied-pmid 15039387?><pub-id pub-id-type="pmid">15039387</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sallusto</surname><given-names>F</given-names></name><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Danieli</surname><given-names>C</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group><article-title>Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products</article-title><source>J Exp Med.</source><year>1995</year><volume>182</volume><issue>2</issue><fpage>389</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1084/jem.182.2.389</pub-id><?supplied-pmid 7629501?><pub-id pub-id-type="pmid">7629501</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonuleit</surname><given-names>H</given-names></name><name><surname>Schmitt</surname><given-names>E</given-names></name><name><surname>Schuler</surname><given-names>G</given-names></name><name><surname>Knop</surname><given-names>J</given-names></name><name><surname>Enk</surname><given-names>AH</given-names></name></person-group><article-title>Induction of interleukin 10&#x02013;producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells</article-title><source>J Exp Med.</source><year>2000</year><volume>192</volume><issue>9</issue><fpage>1213</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1084/jem.192.9.1213</pub-id><?supplied-pmid 11067871?><pub-id pub-id-type="pmid">11067871</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassatella</surname><given-names>MA</given-names></name><name><surname>Meda</surname><given-names>L</given-names></name><name><surname>Bonora</surname><given-names>S</given-names></name><name><surname>Ceska</surname><given-names>M</given-names></name><name><surname>Constantin</surname><given-names>G</given-names></name></person-group><article-title>Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide</article-title><source>J Exp Med.</source><year>1993</year><volume>178</volume><issue>6</issue><fpage>2207</fpage><lpage>2211</lpage><pub-id pub-id-type="doi">10.1084/jem.178.6.2207</pub-id><?supplied-pmid 8245792?><pub-id pub-id-type="pmid">8245792</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mocellin</surname><given-names>S</given-names></name><name><surname>Panelli</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Nagorsen</surname><given-names>D</given-names></name><name><surname>Marincola</surname><given-names>FM</given-names></name></person-group><article-title>The dual role of IL-10</article-title><source>Trends Immunol.</source><year>2003</year><volume>24</volume><issue>1</issue><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/S1471-4906(02)00009-1</pub-id><?supplied-pmid 12495723?><pub-id pub-id-type="pmid">12495723</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macatonia</surname><given-names>SE</given-names></name><name><surname>Hosken</surname><given-names>NA</given-names></name><name><surname>Litton</surname><given-names>M</given-names></name><name><surname>Vieira</surname><given-names>P</given-names></name><name><surname>Hsieh</surname><given-names>C-S</given-names></name><name><surname>Culpepper</surname><given-names>JA</given-names></name><name><surname>Wysocka</surname><given-names>M</given-names></name><name><surname>Trinchieri</surname><given-names>G</given-names></name><name><surname>Murphy</surname><given-names>KM</given-names></name><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group><article-title>Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells</article-title><source>J Immunol.</source><year>1995</year><volume>154</volume><issue>10</issue><fpage>5071</fpage><lpage>5079</lpage><?supplied-pmid 7730613?><pub-id pub-id-type="pmid">7730613</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watford</surname><given-names>WT</given-names></name><name><surname>Moriguchi</surname><given-names>M</given-names></name><name><surname>Morinobu</surname><given-names>A</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>JJ</given-names></name></person-group><article-title>The biology of IL-12: coordinating innate and adaptive immune responses</article-title><source>Cytokine Growth Factor Rev.</source><year>2003</year><volume>14</volume><issue>5</issue><fpage>361</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/S1359-6101(03)00043-1</pub-id><?supplied-pmid 12948519?><pub-id pub-id-type="pmid">12948519</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buelens</surname><given-names>C</given-names></name><name><surname>Willems</surname><given-names>F</given-names></name><name><surname>Delvaux</surname><given-names>A</given-names></name><name><surname>Pi&#x000e9;rard</surname><given-names>G</given-names></name><name><surname>Delville</surname><given-names>JP</given-names></name><name><surname>Velu</surname><given-names>T</given-names></name><name><surname>Goldman</surname><given-names>M</given-names></name></person-group><article-title>Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells</article-title><source>Eur J Immunol.</source><year>1995</year><volume>25</volume><issue>9</issue><fpage>2668</fpage><lpage>2672</lpage><pub-id pub-id-type="doi">10.1002/eji.1830250940</pub-id><?supplied-pmid 7589143?><pub-id pub-id-type="pmid">7589143</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kali&#x00144;ski</surname><given-names>P</given-names></name><name><surname>Hilkens</surname><given-names>CM</given-names></name><name><surname>Wierenga</surname><given-names>EA</given-names></name><name><surname>Kapsenberg</surname><given-names>ML</given-names></name></person-group><article-title>T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal</article-title><source>Immunol Today.</source><year>1999</year><volume>20</volume><issue>12</issue><fpage>561</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1016/S0167-5699(99)01547-9</pub-id><?supplied-pmid 10562707?><pub-id pub-id-type="pmid">10562707</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syrovets</surname><given-names>T</given-names></name><name><surname>B&#x000fc;chele</surname><given-names>B</given-names></name><name><surname>Krauss</surname><given-names>C</given-names></name><name><surname>Laumonnier</surname><given-names>Y</given-names></name><name><surname>Simmet</surname><given-names>T</given-names></name></person-group><article-title>Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-&#x003b1; induction in monocytes by direct interaction with I&#x003ba;B kinases</article-title><source>J Immunol.</source><year>2005</year><volume>174</volume><issue>1</issue><fpage>498</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.1.498</pub-id><?supplied-pmid 15611276?><pub-id pub-id-type="pmid">15611276</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="other">Al-Yasiry ARM, Kiczorowska B. Frankincense-therapeutic properties. Adv Hyg Exp Med Postepy Hig Med Dosw. 2016;70.</mixed-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Stefano</surname><given-names>V</given-names></name><name><surname>Schillaci</surname><given-names>D</given-names></name><name><surname>Cusimano</surname><given-names>MG</given-names></name><name><surname>Rishan</surname><given-names>M</given-names></name><name><surname>Rashan</surname><given-names>L</given-names></name></person-group><article-title>In vitro antimicrobial activity of frankincense oils from Boswellia sacra grown in different locations of the Dhofar region (Oman)</article-title><source>Antibiotics.</source><year>2020</year><volume>9</volume><issue>4</issue><fpage>195</fpage><pub-id pub-id-type="doi">10.3390/antibiotics9040195</pub-id><?supplied-pmid 7235874?><pub-id pub-id-type="pmid">7235874</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmiech</surname><given-names>M</given-names></name><name><surname>Lang</surname><given-names>SJ</given-names></name><name><surname>Werner</surname><given-names>K</given-names></name><name><surname>Rashan</surname><given-names>LJ</given-names></name><name><surname>Syrovets</surname><given-names>T</given-names></name><name><surname>Simmet</surname><given-names>T</given-names></name></person-group><article-title>Comparative analysis of pentacyclic triterpenic acid compositions in oleogum resins of different Boswellia species and their in vitro cytotoxicity against treatment-resistant human breast cancer cells</article-title><source>Molecules.</source><year>2019</year><volume>24</volume><issue>11</issue><fpage>2153</fpage><pub-id pub-id-type="doi">10.3390/molecules24112153</pub-id><?supplied-pmid 6600171?><pub-id pub-id-type="pmid">6600171</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ammon</surname><given-names>HPT</given-names></name></person-group><article-title>Boswellic extracts and 11-keto-&#x000df;-boswellic acids prevent type 1 and type 2 diabetes mellitus by suppressing the expression of proinflammatory cytokines</article-title><source>Phytomedicine.</source><year>2019</year><volume>63</volume><fpage>153002</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2019.153002</pub-id><?supplied-pmid 31301539?><pub-id pub-id-type="pmid">31301539</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Xiang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis</article-title><source>BMC Complement Med Ther.</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>225</fpage><pub-id pub-id-type="doi">10.1186/s12906-020-02985-6</pub-id><?supplied-pmid 32680575?><pub-id pub-id-type="pmid">32680575</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klauke</surname><given-names>A-L</given-names></name><name><surname>Racz</surname><given-names>I</given-names></name><name><surname>Pradier</surname><given-names>B</given-names></name><name><surname>Markert</surname><given-names>A</given-names></name><name><surname>Zimmer</surname><given-names>A</given-names></name><name><surname>Gertsch</surname><given-names>J</given-names></name><name><surname>Zimmer</surname><given-names>A</given-names></name></person-group><article-title>The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain</article-title><source>Eur Neuropsychopharmacol.</source><year>2014</year><volume>24</volume><issue>4</issue><fpage>608</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1016/j.euroneuro.2013.10.008</pub-id><?supplied-pmid 24210682?><pub-id pub-id-type="pmid">24210682</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>CL</given-names></name><name><surname>Liao</surname><given-names>PC</given-names></name><name><surname>Wang</surname><given-names>EI</given-names></name><name><surname>Su</surname><given-names>YC</given-names></name></person-group><article-title>Composition and antimicrobial activity of the leaf and twig oils of Litsea acutivena from Taiwan</article-title><source>Nat Prod Commun.</source><year>2011</year><volume>6</volume><issue>11</issue><fpage>1755</fpage><lpage>1758</lpage><?supplied-pmid 22224304?><pub-id pub-id-type="pmid">22224304</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>IY</given-names></name><name><surname>Lim</surname><given-names>JH</given-names></name><name><surname>Hwang</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Cho</surname><given-names>GS</given-names></name><name><surname>Kim</surname><given-names>WK</given-names></name></person-group><article-title>Anti-ischemic and anti-inflammatory activity of (S)-cis-verbenol</article-title><source>Free Radic Res.</source><year>2010</year><volume>44</volume><issue>5</issue><fpage>541</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.3109/10715761003667562</pub-id><?supplied-pmid 20214504?><pub-id pub-id-type="pmid">20214504</pub-id></element-citation></ref></ref-list></back></article>